<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T04:19:00Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:6261685" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:6261685</identifier>
        <datestamp>2019-05-21</datestamp>
        <setSpec>blackwellopen</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">Mov Disord</journal-id>
              <journal-id journal-id-type="iso-abbrev">Mov. Disord</journal-id>
              <journal-id journal-id-type="doi">10.1002/(ISSN)1531-8257</journal-id>
              <journal-id journal-id-type="publisher-id">MDS</journal-id>
              <journal-title-group>
                <journal-title>Movement Disorders</journal-title>
              </journal-title-group>
              <issn pub-type="ppub">0885-3185</issn>
              <issn pub-type="epub">1531-8257</issn>
              <publisher>
                <publisher-name>John Wiley &amp; Sons, Inc.</publisher-name>
                <publisher-loc>Hoboken, USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC6261685</article-id>
              <article-id pub-id-type="pmcid">PMC6261685</article-id>
              <article-id pub-id-type="pmc-uid">6261685</article-id>
              <article-id pub-id-type="pmid">30264896</article-id>
              <article-id pub-id-type="doi">10.1002/mds.27460</article-id>
              <article-id pub-id-type="publisher-id">MDS27460</article-id>
              <article-categories>
                <subj-group subj-group-type="overline">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="heading">
                  <subject>Research Articles</subject>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Speech treatment in Parkinson's disease: Randomized controlled trial (RCT)</article-title>
                <alt-title alt-title-type="right-running-head">SPEECH TREATMENT IN PARKINSON'S DISEASE: RCT</alt-title>
                <alt-title alt-title-type="left-running-head">RAMIG ET AL</alt-title>
              </title-group>
              <contrib-group>
                <contrib id="mds27460-cr-0001" contrib-type="author" corresp="yes">
                  <name>
                    <surname>Ramig</surname>
                    <given-names>Lorraine</given-names>
                  </name>
                  <degrees>PhD, CCC‐SLP</degrees>
                  <address>
                    <email>ramig@colorado.edu</email>
                    <email>lori.ramig@gmail.com</email>
                  </address>
                  <xref ref-type="aff" rid="mds27460-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="mds27460-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="mds27460-aff-0003">
                    <sup>3</sup>
                  </xref>
                  <xref ref-type="aff" rid="mds27460-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="mds27460-cr-0002" contrib-type="author">
                  <name>
                    <surname>Halpern</surname>
                    <given-names>Angela</given-names>
                  </name>
                  <degrees>MS, CCC‐SLP</degrees>
                  <xref ref-type="aff" rid="mds27460-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="mds27460-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="mds27460-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="mds27460-cr-0003" contrib-type="author">
                  <name>
                    <surname>Spielman</surname>
                    <given-names>Jennifer</given-names>
                  </name>
                  <degrees>MA, CCC‐SLP</degrees>
                  <xref ref-type="aff" rid="mds27460-aff-0001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="mds27460-aff-0002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib id="mds27460-cr-0004" contrib-type="author">
                  <name>
                    <surname>Fox</surname>
                    <given-names>Cynthia</given-names>
                  </name>
                  <degrees>PhD, CCC‐SLP</degrees>
                  <xref ref-type="aff" rid="mds27460-aff-0002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="aff" rid="mds27460-aff-0004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib id="mds27460-cr-0005" contrib-type="author">
                  <name>
                    <surname>Freeman</surname>
                    <given-names>Katherine</given-names>
                  </name>
                  <degrees>DrPH</degrees>
                  <xref ref-type="aff" rid="mds27460-aff-0005">
                    <sup>5</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="mds27460-aff-0001" content-type="private-address">
                <label>
                  <sup>1</sup>
                </label>
                <institution>University of Colorado‐Boulder</institution>
                <named-content content-type="city">Boulder</named-content>
                <named-content content-type="country-part">Colorado</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="mds27460-aff-0002" content-type="private-address">
                <label>
                  <sup>2</sup>
                </label>
                <institution>National Center for Voice and Speech‐Denver</institution>
                <named-content content-type="city">Denver</named-content>
                <named-content content-type="country-part">Colorado</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="mds27460-aff-0003" content-type="private-address">
                <label>
                  <sup>3</sup>
                </label>
                <institution>Columbia University‐New York City</institution>
                <named-content content-type="city">New York</named-content>
                <named-content content-type="country-part">New York</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="mds27460-aff-0004" content-type="private-address">
                <label>
                  <sup>4</sup>
                </label>
                <institution>LSVT Global, Inc.‐Tucson</institution>
                <named-content content-type="city">Tucson</named-content>
                <named-content content-type="country-part">Arizona</named-content>
                <country country="US">USA</country>
              </aff>
              <aff id="mds27460-aff-0005" content-type="private-address">
                <label>
                  <sup>5</sup>
                </label>
                <institution>Florida Atlantic University‐Boca Raton</institution>
                <named-content content-type="city">Boca Raton, Florida</named-content>
                <country country="US">USA</country>
              </aff>
              <author-notes>
                <corresp id="correspondenceTo"><label>*</label><bold>Correspondence to:</bold> Dr. Lorraine Ramig, University of Colorado‐Boulder, National Center for Voice and Speech‐Denver, Columbia University‐New York City, LSVT Global, Inc., 30 East 95th Street 2‐D, New York, NY 10128, USA; E‐mail: <email>ramig@colorado.edu</email>; <email>lori.ramig@gmail.com</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>28</day>
                <month>9</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="ppub">
                <month>11</month>
                <year>2018</year>
              </pub-date>
              <volume>33</volume>
              <issue>11</issue>
              <issue-id pub-id-type="doi">10.1002/mds.v33.11</issue-id>
              <fpage>1777</fpage>
              <lpage>1791</lpage>
              <history>
                <date date-type="received">
                  <day>20</day>
                  <month>2</month>
                  <year>2018</year>
                </date>
                <date date-type="rev-recd">
                  <day>07</day>
                  <month>5</month>
                  <year>2018</year>
                </date>
                <date date-type="accepted">
                  <day>22</day>
                  <month>5</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <!--<copyright-statement content-type="issue-copyright"> &#x000a9; 2018 International Parkinson and Movement Disorder Society <copyright-statement>-->
                <copyright-statement content-type="article-copyright">© 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.</copyright-statement>
                <license license-type="creativeCommonsBy-nc-nd">
                  <license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link> License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:type="simple" xlink:href="file:MDS-33-1777.pdf"/>
              <abstract>
                <title>ABSTRACT</title>
                <sec id="mds27460-sec-0001">
                  <title>Background</title>
                  <p>As many as 89% of people with Parkinson's disease (PD) develop speech disorders.</p>
                </sec>
                <sec id="mds27460-sec-0002">
                  <title>Objectives</title>
                  <p>This randomized controlled trial evaluated two speech treatments for PD matched in intensive dosage and high‐effort mode of delivery, differing in subsystem target: voice (respiratory‐laryngeal) versus articulation (orofacial‐articulatory).</p>
                </sec>
                <sec id="mds27460-sec-0003">
                  <title>Methods</title>
                  <p>PD participants were randomized to 1‐month LSVT LOUD (voice), LSVT ARTIC (articulation), or UNTXPD (untreated) groups. Speech clinicians specializing in PD delivered treatment. Primary outcome was sound pressure level (SPL) in reading and spontaneous speech, and secondary outcome was participant‐reported Modified Communication Effectiveness Index (CETI‐M), evaluated at baseline, 1, and 7 months. Healthy controls were matched by age and sex.</p>
                </sec>
                <sec id="mds27460-sec-0004">
                  <title>Results</title>
                  <p>At baseline, the combined PD group (n = 64) was significantly worse than healthy controls (n = 20) for SPL (<italic>P</italic> &lt; 0.05) and CETI‐M (<italic>P</italic> = 0.0001). At 1 and 7 months, SPL between‐group comparisons showed greater improvements for LSVT LOUD (n = 22) than LSVT ARTIC (n = 20; <italic>P</italic> &lt; 0.05) and UNTXPD (n = 22; <italic>P</italic> &lt; 0.05). Sound pressure level differences between LSVT ARTIC and UNTXPD at 1 and 7 months were not significant (<italic>P</italic> &gt; 0.05). For CETI‐M, between‐group comparisons showed greater improvements for LSVT LOUD and LSVT ARTIC than UNTXPD at 1 month (<italic>P</italic> = 0.02; <italic>P</italic> = 0.02). At 7 months, CETI‐M between‐group differences were not significant (<italic>P</italic> = 0.08). Within‐group CETI‐M improvements for LSVT LOUD were maintained through 7 months (<italic>P</italic> = 0.0011).</p>
                </sec>
                <sec id="mds27460-sec-0005">
                  <title>Conclusions</title>
                  <p>LSVT LOUD showed greater improvements than both LSVT ARTIC and UNTXPD for SPL at 1 and 7 months. For CETI‐M, both LSVT LOUD and LSVT ARTIC improved at 1 month relative to UNTXPD. Only LSVT LOUD maintained CETI‐M improvements at 7 months. © 2018 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society</p>
                </sec>
              </abstract>
              <kwd-group kwd-group-type="author-generated">
                <kwd id="mds27460-kwd-0001">speech treatment</kwd>
                <kwd id="mds27460-kwd-0002">RCT</kwd>
                <kwd id="mds27460-kwd-0003">Parkinson's disease</kwd>
                <kwd id="mds27460-kwd-0004">voice</kwd>
                <kwd id="mds27460-kwd-0005">articulation</kwd>
              </kwd-group>
              <funding-group>
                <award-group>
                  <funding-source>LSVT Global, Inc., Tucson, Arizona</funding-source>
                </award-group>
                <award-group>
                  <funding-source>National Institutes of Health‐National Institute of Deafness and Other Communication Disorders (NIH‐NIDCD)</funding-source>
                  <award-id>R01 DC01150</award-id>
                </award-group>
                <award-group>
                  <funding-source>LSVT Global, Inc.</funding-source>
                </award-group>
                <award-group>
                  <funding-source>National Institutes of Health‐National Institute of Deafness and Other Communication Disorders</funding-source>
                  <award-id>R01 DC01150</award-id>
                </award-group>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="4"/>
                <page-count count="15"/>
                <word-count count="12330"/>
              </counts>
              <custom-meta-group>
                <custom-meta>
                  <meta-name>source-schema-version-number</meta-name>
                  <meta-value>2.0</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>component-id</meta-name>
                  <meta-value>mds27460</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>cover-date</meta-name>
                  <meta-value>November 2018</meta-value>
                </custom-meta>
                <custom-meta>
                  <meta-name>details-of-publishers-convertor</meta-name>
                  <meta-value>Converter:WILEY_ML3GV2_TO_NLMPMC version:5.6.2.1 mode:remove_FC converted:15.05.2019</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <fn-group id="mds27460-ntgp-0001">
                <fn id="mds27460-note-0001">
                  <p>Full financial disclosures and author roles may be found in the online version of this article.</p>
                </fn>
              </fn-group>
            </notes>
          </front>
          <body>
            <p>Research indicates that as many as 89% of patients living with Parkinson's disease (PD) develop speech signs,<xref rid="mds27460-bib-0001" ref-type="ref">1</xref>, <xref rid="mds27460-bib-0002" ref-type="ref">2</xref>, <xref rid="mds27460-bib-0003" ref-type="ref">3</xref>, <xref rid="mds27460-bib-0004" ref-type="ref">4</xref>, <xref rid="mds27460-bib-0005" ref-type="ref">5</xref> termed <italic>hypokinetic dysarthria</italic>,<xref rid="mds27460-bib-0006" ref-type="ref">6</xref>, <xref rid="mds27460-bib-0007" ref-type="ref">7</xref> including disorders of <italic>voice</italic> (e.g., reduced loudness, monotone, and hoarse, breathy quality),<xref rid="mds27460-bib-0008" ref-type="ref">8</xref>, <xref rid="mds27460-bib-0009" ref-type="ref">9</xref>, <xref rid="mds27460-bib-0010" ref-type="ref">10</xref>, <xref rid="mds27460-bib-0011" ref-type="ref">11</xref>, <xref rid="mds27460-bib-0012" ref-type="ref">12</xref>, <xref rid="mds27460-bib-0013" ref-type="ref">13</xref>, <xref rid="mds27460-bib-0014" ref-type="ref">14</xref>
<italic>articulation</italic> (e.g., imprecise consonants, vowel centralization),<xref rid="mds27460-bib-0015" ref-type="ref">15</xref>, <xref rid="mds27460-bib-0016" ref-type="ref">16</xref>, <xref rid="mds27460-bib-0017" ref-type="ref">17</xref>, <xref rid="mds27460-bib-0018" ref-type="ref">18</xref>, <xref rid="mds27460-bib-0019" ref-type="ref">19</xref>, <xref rid="mds27460-bib-0020" ref-type="ref">20</xref>, <xref rid="mds27460-bib-0021" ref-type="ref">21</xref>, <xref rid="mds27460-bib-0022" ref-type="ref">22</xref>, <xref rid="mds27460-bib-0023" ref-type="ref">23</xref>, <xref rid="mds27460-bib-0024" ref-type="ref">24</xref>, <xref rid="mds27460-bib-0025" ref-type="ref">25</xref> and <italic>rate</italic> (increased, decreased, or variable).<xref rid="mds27460-bib-0026" ref-type="ref">26</xref>, <xref rid="mds27460-bib-0027" ref-type="ref">27</xref>, <xref rid="mds27460-bib-0028" ref-type="ref">28</xref> In contrast to previous reports suggesting long latencies from PD diagnosis to onset of identifiable speech signs (median 84 months),<xref rid="mds27460-bib-0029" ref-type="ref">29</xref> more recent data from prospective studies using objective, reliable measures sensitive to speech changes suggest that speech signs may appear early<xref rid="mds27460-bib-0022" ref-type="ref">22</xref>, <xref rid="mds27460-bib-0030" ref-type="ref">30</xref>, <xref rid="mds27460-bib-0031" ref-type="ref">31</xref>, <xref rid="mds27460-bib-0032" ref-type="ref">32</xref>, <xref rid="mds27460-bib-0033" ref-type="ref">33</xref> and progress in severity,<xref rid="mds27460-bib-0025" ref-type="ref">25</xref>, <xref rid="mds27460-bib-0033" ref-type="ref">33</xref>, <xref rid="mds27460-bib-0034" ref-type="ref">34</xref>, <xref rid="mds27460-bib-0035" ref-type="ref">35</xref>, <xref rid="mds27460-bib-0036" ref-type="ref">36</xref>, <xref rid="mds27460-bib-0037" ref-type="ref">37</xref>, <xref rid="mds27460-bib-0038" ref-type="ref">38</xref> leading to significant declines in functional communication and quality of life.<xref rid="mds27460-bib-0004" ref-type="ref">4</xref>, <xref rid="mds27460-bib-0031" ref-type="ref">31</xref>, <xref rid="mds27460-bib-0039" ref-type="ref">39</xref> Reductions in vocal loudness are among the first and most pervasive changes in speech,<xref rid="mds27460-bib-0001" ref-type="ref">1</xref>, <xref rid="mds27460-bib-0006" ref-type="ref">6</xref>, <xref rid="mds27460-bib-0007" ref-type="ref">7</xref>, <xref rid="mds27460-bib-0014" ref-type="ref">14</xref>, <xref rid="mds27460-bib-0040" ref-type="ref">40</xref> having negative effects on speech intelligibility when patients are not sufficiently audible to be heard by listeners.<xref rid="mds27460-bib-0008" ref-type="ref">8</xref>, <xref rid="mds27460-bib-0041" ref-type="ref">41</xref>, <xref rid="mds27460-bib-0042" ref-type="ref">42</xref>, <xref rid="mds27460-bib-0043" ref-type="ref">43</xref>, <xref rid="mds27460-bib-0044" ref-type="ref">44</xref>
</p>
            <p>The neural bases of speech disorders in PD are complex. Reductions in vocal loudness are attributed partly to hypokinesia (reduced amplitude of movement) and rigidity caused by underlying dopaminergic deficiency.<xref rid="mds27460-bib-0042" ref-type="ref">42</xref>, <xref rid="mds27460-bib-0045" ref-type="ref">45</xref>, <xref rid="mds27460-bib-0046" ref-type="ref">46</xref>, <xref rid="mds27460-bib-0047" ref-type="ref">47</xref>, <xref rid="mds27460-bib-0048" ref-type="ref">48</xref>, <xref rid="mds27460-bib-0049" ref-type="ref">49</xref> However, abnormalities in central sensory processing (reduced awareness of soft voice), internal cueing (difficulty self‐generating increased loudness), and self‐monitoring of speech output are now reported to contribute.<xref rid="mds27460-bib-0050" ref-type="ref">50</xref>, <xref rid="mds27460-bib-0051" ref-type="ref">51</xref>, <xref rid="mds27460-bib-0052" ref-type="ref">52</xref>, <xref rid="mds27460-bib-0053" ref-type="ref">53</xref>, <xref rid="mds27460-bib-0054" ref-type="ref">54</xref>, <xref rid="mds27460-bib-0055" ref-type="ref">55</xref>, <xref rid="mds27460-bib-0056" ref-type="ref">56</xref>, <xref rid="mds27460-bib-0057" ref-type="ref">57</xref>, <xref rid="mds27460-bib-0058" ref-type="ref">58</xref>, <xref rid="mds27460-bib-0059" ref-type="ref">59</xref>, <xref rid="mds27460-bib-0060" ref-type="ref">60</xref> These central sensory and cueing deficits may explain why speech disorders in PD are generally unresponsive to pharmacological or neurosurgical interventions alone<xref rid="mds27460-bib-0040" ref-type="ref">40</xref>, <xref rid="mds27460-bib-0061" ref-type="ref">61</xref>, <xref rid="mds27460-bib-0062" ref-type="ref">62</xref>, <xref rid="mds27460-bib-0063" ref-type="ref">63</xref>, <xref rid="mds27460-bib-0064" ref-type="ref">64</xref>, <xref rid="mds27460-bib-0065" ref-type="ref">65</xref> given that such treatments primarily address motor deficits,<xref rid="mds27460-bib-0012" ref-type="ref">12</xref>, <xref rid="mds27460-bib-0061" ref-type="ref">61</xref>, <xref rid="mds27460-bib-0066" ref-type="ref">66</xref>, <xref rid="mds27460-bib-0067" ref-type="ref">67</xref>, <xref rid="mds27460-bib-0068" ref-type="ref">68</xref>, <xref rid="mds27460-bib-0069" ref-type="ref">69</xref>, <xref rid="mds27460-bib-0070" ref-type="ref">70</xref>, <xref rid="mds27460-bib-0071" ref-type="ref">71</xref>, <xref rid="mds27460-bib-0072" ref-type="ref">72</xref>, <xref rid="mds27460-bib-0073" ref-type="ref">73</xref> and why traditional speech therapy effects often are not sustained because sensory processing disorders typically are not addressed in these approaches.<xref rid="mds27460-bib-0074" ref-type="ref">74</xref>, <xref rid="mds27460-bib-0075" ref-type="ref">75</xref>, <xref rid="mds27460-bib-0076" ref-type="ref">76</xref>, <xref rid="mds27460-bib-0077" ref-type="ref">77</xref>, <xref rid="mds27460-bib-0078" ref-type="ref">78</xref>
</p>
            <p>Since the 1990s, development and evaluation of the Lee Silverman Voice Treatment (LSVT LOUD®) has advanced speech treatment efficacy for patients with PD by addressing the complex etiology of the speech disorder.<xref rid="mds27460-bib-0041" ref-type="ref">41</xref>, <xref rid="mds27460-bib-0052" ref-type="ref">52</xref>, <xref rid="mds27460-bib-0079" ref-type="ref">79</xref> LSVT LOUD differs from traditional PD speech treatment in key ways: (1) the singular target of treatment is <italic>voice</italic> (respiratory‐laryngeal subsystem), specifically increasing amplitude of vocal motor output to override hypokinesia throughout the speech mechanism<xref rid="mds27460-bib-0048" ref-type="ref">48</xref>, <xref rid="mds27460-bib-0080" ref-type="ref">80</xref>; (2) treatment is intensive (16 individual 1‐hour sessions in 1 month, with a high‐effort mode of delivery), consistent with principles promoting activity‐dependent neuroplasticity<xref rid="mds27460-bib-0081" ref-type="ref">81</xref>, <xref rid="mds27460-bib-0082" ref-type="ref">82</xref>, <xref rid="mds27460-bib-0083" ref-type="ref">83</xref>, <xref rid="mds27460-bib-0084" ref-type="ref">84</xref>, <xref rid="mds27460-bib-0085" ref-type="ref">85</xref>, <xref rid="mds27460-bib-0086" ref-type="ref">86</xref>; and (3) the sensory component of the speech disorder is addressed by retraining sensory perception of normal loudness (self‐monitoring) and internal cueing (self‐generating normal loudness).<xref rid="mds27460-bib-0042" ref-type="ref">42</xref>, <xref rid="mds27460-bib-0050" ref-type="ref">50</xref>, <xref rid="mds27460-bib-0052" ref-type="ref">52</xref> In contrast, traditional speech treatment for PD focused on multiple targets (loudness, respiration, articulation, and rate), was delivered at low dosage (once/twice a week) without high‐effort training, and did not directly address sensory and cueing deficits.<xref rid="mds27460-bib-0075" ref-type="ref">75</xref>
</p>
            <p>A previous randomized controlled trial (RCT) in PD compared LSVT LOUD voice treatment (respiratory‐laryngeal target) to an alternative respiratory treatment (respiratory target only), both designed to increase vocal loudness and retrain sensory perception and internal cueing of normal loudness. Outcomes demonstrated that LSVT LOUD produced significant immediate and long‐term improvements (through 24 months) in a key acoustic measure—sound pressure level (SPL), the objective correlate of loudness—supporting treatment efficacy. Furthermore, the magnitude of these changes exceeded those following treatment matched in dosage and mode of delivery, but focusing only on the respiratory system.<xref rid="mds27460-bib-0087" ref-type="ref">87</xref>, <xref rid="mds27460-bib-0088" ref-type="ref">88</xref>, <xref rid="mds27460-bib-0089" ref-type="ref">89</xref> A second RCT<xref rid="mds27460-bib-0090" ref-type="ref">90</xref> compared LSVT LOUD to untreated control groups (untreated PD [UNTXPD] and healthy controls [HCs]) and demonstrated that changes in SPL following LSVT LOUD exceeded those for UNTXPD and were maintained for 6 months post‐treatment.<xref rid="mds27460-bib-0090" ref-type="ref">90</xref> Effect sizes (ESs) for SPL in these RCTs ranged from 0.65 to 2.03.<xref rid="mds27460-bib-0051" ref-type="ref">51</xref>, <xref rid="mds27460-bib-0087" ref-type="ref">87</xref>, <xref rid="mds27460-bib-0088" ref-type="ref">88</xref>, <xref rid="mds27460-bib-0089" ref-type="ref">89</xref>, <xref rid="mds27460-bib-0090" ref-type="ref">90</xref> We concluded from the comparison of two treatment targets, both focused on improving vocal loudness, that the target of <italic>voice</italic> was critical for improvements whereas the <italic>respiratory</italic> target alone was insufficient.<xref rid="mds27460-bib-0087" ref-type="ref">87</xref>, <xref rid="mds27460-bib-0088" ref-type="ref">88</xref>, <xref rid="mds27460-bib-0089" ref-type="ref">89</xref>
</p>
            <p>Following LSVT LOUD, improvements were also documented in objective measures of articulation,<xref rid="mds27460-bib-0019" ref-type="ref">19</xref>, <xref rid="mds27460-bib-0020" ref-type="ref">20</xref>, <xref rid="mds27460-bib-0091" ref-type="ref">91</xref> rate,<xref rid="mds27460-bib-0087" ref-type="ref">87</xref> intonation,<xref rid="mds27460-bib-0089" ref-type="ref">89</xref> aerodynamics,<xref rid="mds27460-bib-0092" ref-type="ref">92</xref> and perceptual measures of speech intelligibility<xref rid="mds27460-bib-0041" ref-type="ref">41</xref>, <xref rid="mds27460-bib-0087" ref-type="ref">87</xref> and voice quality,<xref rid="mds27460-bib-0009" ref-type="ref">9</xref> as well as measures of swallowing<xref rid="mds27460-bib-0093" ref-type="ref">93</xref> and facial expression.<xref rid="mds27460-bib-0094" ref-type="ref">94</xref> These findings suggest that driving amplitude through a single treatment target of <italic>voice</italic> may optimize treatment efficiency through engagement of biomechanical and neurophysiologic linkages between the vocal and articulatory subsystems.<xref rid="mds27460-bib-0095" ref-type="ref">95</xref>, <xref rid="mds27460-bib-0096" ref-type="ref">96</xref>. Given that articulatory movements have been shown to influence a range of laryngeal behaviors, with some correlating strongly with vocal loudness,<xref rid="mds27460-bib-0095" ref-type="ref">95</xref>, <xref rid="mds27460-bib-0097" ref-type="ref">97</xref>, <xref rid="mds27460-bib-0098" ref-type="ref">98</xref>, <xref rid="mds27460-bib-0099" ref-type="ref">99</xref>, <xref rid="mds27460-bib-0100" ref-type="ref">100</xref> it could be speculated that directly targeting the articulatory subsystem in a similarly intensive manner would have an equal or greater potential for generating speech mechanism‐wide improvements.</p>
            <p>To address this, treatment for disordered <italic>articulation</italic> (orofacial‐articulatory subsystem) was chosen as the <italic>treatment target comparator</italic> for the current study. Although articulation disorders are commonly observed in PD,<xref rid="mds27460-bib-0020" ref-type="ref">20</xref>, <xref rid="mds27460-bib-0021" ref-type="ref">21</xref>, <xref rid="mds27460-bib-0025" ref-type="ref">25</xref> and have been treated with modest success,<xref rid="mds27460-bib-0101" ref-type="ref">101</xref>, <xref rid="mds27460-bib-0102" ref-type="ref">102</xref>, <xref rid="mds27460-bib-0103" ref-type="ref">103</xref> they have not been treated intensively,<xref rid="mds27460-bib-0104" ref-type="ref">104</xref>, <xref rid="mds27460-bib-0105" ref-type="ref">105</xref> with the goal to increase amplitude of articulatory motor output to override speech mechanism hypokinesia while retraining sensory perception and internal cueing of articulatory effort.</p>
            <p>To dissociate the specific contributions of treatment intensity and target, the current RCT compared a treatment protocol targeting <italic>voice</italic> (LSVT LOUD), with a treatment protocol targeting <italic>articulation</italic> (LSVT ARTIC™), equally matched for intensive dosage and mode of delivery and contrasted with no treatment (UNTXPD). We chose not to use a sham treatment to adhere to the ethical principle of equipoise<xref rid="mds27460-bib-0106" ref-type="ref">106</xref> and to avoid placing undue time and effort burden on the UNTXPD participants without the potential of therapeutic effect benefit.<xref rid="mds27460-bib-0107" ref-type="ref">107</xref> Rather, the UNTXPD group represents natural progression of speech disorders in PD within the framework of scheduled trial visits and medical treatment. This study responds to the need to establish relative efficacy of speech treatments for PD<xref rid="mds27460-bib-0108" ref-type="ref">108</xref>, <xref rid="mds27460-bib-0109" ref-type="ref">109</xref> and follows CONSORT reporting guidelines for behavioral RCTs.<xref rid="mds27460-bib-0110" ref-type="ref">110</xref>, <xref rid="mds27460-bib-0111" ref-type="ref">111</xref>
</p>
            <p>Outcomes were measured at 1 and 7 months. The primary outcome reflects amplitude change measured using SPL. The secondary outcome reflects functional change measured by the participant‐reported Modified Communication Effectiveness Index (CETI‐M).</p>
            <p>The following are bidirectional hypotheses, a conservative approach which allows for the possibility of differences in either direction:</p>
            <p><bold>Hypothesis 1:</bold> There is a significant difference at baseline between the combined group of all PD participants and HC participants regarding SPL and CETI‐M.</p>
            <p><bold>Hypothesis 2:</bold> There are significant differences among LSVT LOUD, LSVT ARTIC, and UNTXPD regarding changes in SPL over 7 months.</p>
            <p><bold>Hypothesis 3:</bold> There are significant differences among LSVT LOUD, LSVT ARTIC, and UNTXPD regarding changes in CETI‐M over 7 months.</p>
            <sec id="mds27460-sec-0007">
              <title>Materials and Methods</title>
              <sec id="mds27460-sec-0008">
                <title>Trial Design</title>
                <p>The design was an unblinded RCT in PD participants using two behavioral speech treatments relative to untreated PD controls. Clinicians administering treatment could not be blinded; participants were aware that they were receiving one of two possible treatments, but specific treatment names (LSVT LOUD, LSVT ARTIC) were never disclosed. UNTXPD were offered complementary treatment poststudy.</p>
                <p>Speech data were collected at the National Center for Voice and Speech‐Denver, an affiliate of the University of Colorado‐Boulder (UCB). Additional screening/inclusion and demographic data were collected from neurology and otolaryngology offices in Denver, and the radiology department of the University of Colorado Health Sciences Center‐Denver (UCHSC).</p>
              </sec>
              <sec id="mds27460-sec-0009">
                <title>Participants</title>
                <p>PD patients were recruited from outpatient clinics, support groups, and physicians. HCs were recruited through senior centers and service organizations. All participants (aged 45–85 years) were eligible if they had normal hearing for age and had not smoked within the preceding 4 years.<xref rid="mds27460-bib-0112" ref-type="ref">112</xref> PD patients were required to be diagnosed by a neurologist, clinically stable on their antiparkinsonian medication, and within Stages I to IV on the Hoehn and Yahr scale.<xref rid="mds27460-bib-0113" ref-type="ref">113</xref> Patients were included if they had no more than mild dementia (Mini‐Mental State Examination [MMSE] ≥25),<xref rid="mds27460-bib-0114" ref-type="ref">114</xref> no greater than moderate depression (Beck Depression Inventory‐II [BDI‐II] ≤24),<xref rid="mds27460-bib-0115" ref-type="ref">115</xref> and any severity of speech and voice disorder (see Supporting Information). Primary exclusion criteria for patients included diagnosis of atypical PD or other neurological condition at time of screening, speech or voice disorder unrelated to PD, neurosurgical treatment, laryngeal surgery or pathology, intensive speech treatment within 2 years, LSVT LOUD at any time, or swallowing problem requiring immediate attention (see Supporting Information).</p>
                <p>The study was approved by institutional review boards (IRBs) at UCB and the UCHSC, with written informed consent obtained from all participants; all procedures for de‐identifying shared data were followed. <ext-link ext-link-type="uri" xlink:href="http://clinicaltrials.gov">ClinicalTrials.gov</ext-link> Identifier: NCT00123084.</p>
              </sec>
              <sec id="mds27460-sec-0010">
                <title>Screening and Randomization</title>
                <p>Initial eligibility screening occurred by telephone. Those who satisfied the phone screening (N = 106; 81 PD and 25 HC) participated in face‐to‐face screenings of speech, voice, hearing, depression (BDI‐II), and cognition (MMSE). If this screening was successful, participants underwent videolaryngostroboscopy (Ear Nose Throat [ENT] examination) and modified barium swallow examinations for further screening<xref rid="mds27460-bib-0116" ref-type="ref">116</xref>, <xref rid="mds27460-bib-0117" ref-type="ref">117</xref>, <xref rid="mds27460-bib-0118" ref-type="ref">118</xref> (see Supporting Information).</p>
                <p>Sixty‐four PD participants met inclusion criteria and were randomized to LSVT LOUD, LSVT ARTIC, and UNTXPD using a ratio of 1:1:1. Twenty HC participants met inclusion criteria. Randomization used a minimization program that incorporated inclusion/exclusion criteria for each participant. A statistician generated a written allocation from the program, which was forwarded to the treating clinician (assigned according to availability) to enroll the participant (Fig. <xref rid="mds27460-fig-0001" ref-type="fig">1</xref>). All participants were compensated for their time.</p>
                <fig fig-type="Figure" xml:lang="en" id="mds27460-fig-0001" orientation="portrait" position="float">
                  <label>Figure 1</label>
                  <caption>
                    <p>CONSORT diagram outlining the flow of participants through the trial. PD‐Parkinson's disease; HC‐Healthy Control; BDI‐II Beck Depression Inventory‐II; MMSE‐Mini Mental Status Exam; ENT‐Ear Nose Throat examination.</p>
                  </caption>
                  <graphic id="nlm-graphic-1" xlink:href="MDS-33-1777-g001"/>
                </fig>
              </sec>
              <sec id="mds27460-sec-0011">
                <title>Treating Speech Clinicians</title>
                <p>Speech treatments were administered by three speech clinicians specializing in treating PD and certified in LSVT LOUD treatment delivery. The principal investigators and these clinicians developed and extensively piloted LSVT ARTIC.<xref rid="mds27460-bib-0119" ref-type="ref">119</xref>, <xref rid="mds27460-bib-0120" ref-type="ref">120</xref>, <xref rid="mds27460-bib-0121" ref-type="ref">121</xref> Clinicians followed established protocols for both treatments, provided the same encouragement and positive reinforcement during treatment, and conferred frequently to ensure treatment fidelity. All clinicians were compliant with IRB requirements and trained according to the University's required standards of clinical research.<xref rid="mds27460-bib-0122" ref-type="ref">122</xref>, <xref rid="mds27460-bib-0123" ref-type="ref">123</xref>
</p>
              </sec>
              <sec id="mds27460-sec-0012">
                <title>Treatments</title>
                <p>LSVT LOUD and LSVT ARTIC are PD‐specific, neuroplasticity‐principled, standardized protocols, matched on all key variables (intensive dosage, high‐effort exercises, amplitude rescaling, and sensory retraining) and differing only in treatment target (Table <xref rid="mds27460-tbl-0001" ref-type="table">1</xref>).</p>
                <table-wrap id="mds27460-tbl-0001" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 1</label>
                  <caption>
                    <p>Comparison of LSVT LOUD and LSVT ARTIC speech therapy for PD</p>
                  </caption>
                  <table frame="hsides" rules="cols">
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <col align="left" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1" colspan="1"/>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT LOUD</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT ARTIC</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1">Focus of treatment</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Loudness</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Enunciation</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Dosage</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Increased movement amplitude directed predominately to respiratory‐laryngeal systems</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Increased movement amplitude directed predominately to orofacial‐articulatory system</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1">Individual treatment session of 1 hour, 4 consecutive days per week over a 4‐week period</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Individual treatment session of 1 hour, 4 consecutive days per week over a 4‐week period</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" valign="top" rowspan="1" colspan="1">Effort</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Push for maximum participant perceived effort</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Push for maximum participant perceived effort</td>
                      </tr>
                      <tr>
                        <td colspan="3" align="left" valign="top" rowspan="1">
                          <bold>Daily Exercises, minutes 1 to 30</bold>
                        </td>
                      </tr>
                      <tr>
                        <td rowspan="2" align="left" valign="top" colspan="1">Maximum sustained movements completing multiple repetitions of tasks, minutes 1 to 12</td>
                        <td rowspan="2" align="left" valign="top" colspan="1">Sustain the vowel “ah” in a good‐quality, loud voice, for as long as possible</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Sustain articulatory placement for “p” (lips closed) and “t” (tongue tip behind upper teeth) with Iowa Oral Pressure Instrument (IOPI); hold for 4 second for each trial</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Repeat as many as possible in 5‐second trials, each of the following single consonants with precise articulation (voiceless productions): /p/ /t/ /k/</td>
                      </tr>
                      <tr>
                        <td rowspan="2" align="left" valign="top" colspan="1">Directional movements completing multiple repetitions of tasks, minutes 13 to 23</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Say the vowel “ah” in a good‐quality, loud voice gliding high in pitch; hold for 5 seconds</td>
                        <td rowspan="2" align="left" valign="top" colspan="1">Repeat as many as possible in 5‐second trials, each of the following minimal pair combinations with precise articulation: /t‐k/, /n‐g/, “oo‐ee,” and “oo‐ah”</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Say the vowel “ah” in a good‐quality, loud voice gliding low in pitch; hold for 5 seconds</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" valign="top" rowspan="1" colspan="1">Functional movements, minutes 24 to 30</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant reads 10 self‐generated phrases he/she says daily in functional living (e.g., “Good morning”) using the same effort and loudness as he/she did during the maximum sustained movements exercise</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant reads 10 self‐generated phrases he/she says daily in functional living (e.g., “Good morning”) using the same effort for enunciation as he/she did during the maximum sustained movements exercise</td>
                      </tr>
                      <tr>
                        <td colspan="3" align="left" valign="top" rowspan="1">
                          <bold>Hierarchy Exercises, minutes 31 to 55</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Purpose</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Train rescaled vocal loudness achieved in the Daily Exercises into context‐specific and variable speaking activities</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Train rescaled enunciation achieved in the Daily Exercises into context‐specific and variable speaking activities</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Method</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Incorporate multiple repetitions of reading and conversation tasks with a focus on vocal loudness</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Incorporate multiple repetitions of reading and conversation tasks with a focus on enunciate</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" valign="top" rowspan="1" colspan="1">Tasks</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Tasks increase in length of utterance and difficulty across weeks, progressing from words to phrases to sentences to reading to conversation, and can be tailored to each participant's goals (e.g., communicate at work or with caregivers) and interests (e.g., speak on topics of golf, cooking)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Tasks increase in length of utterance and difficulty across weeks, progressing from words to phrases to sentences to reading to conversation, and can be tailored to each participant's goals (e.g., communicate at work or with caregivers) and interests (e.g., speak on topics of golf, cooking)</td>
                      </tr>
                      <tr>
                        <td colspan="3" align="left" valign="top" rowspan="1">
                          <bold>Assign Homework Exercises to be completed outside of the therapy room, minutes 56 to 60</bold>
                        </td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Duration and repetitions on treatment days (4 days/week)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Subset of the Daily Exercises and Hierarchy Exercises; 10 minutes, performed once per day</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Subset of the Daily Exercises and Hierarchy Exercises; 10 minutes, performed once per day</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Duration and repetitions on nontreatment days (3 days/week)</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Subset of the Daily Exercises and Hierarchy Exercises; 15 minutes, performed twice per day</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Subset of the Daily Exercises and Hierarchy Exercises; 15 minutes, performed twice per day</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Conversational Carryover Assignment</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant is to use the louder voice practiced in exercises in a real‐world communication situation</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant is to use enunciated speech practiced in exercises in a real‐world communication situation</td>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <td align="left" valign="top" rowspan="1" colspan="1">Difficulty level</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Matched to the level of the hierarchy where the participant is in treatment</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Matched to the level of the hierarchy where the participant is in treatment</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">
                          <bold>Shaping techniques</bold>
                        </td>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Purpose and approach</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Train vocal loudness that is healthy and within normal limits (i.e., no unwanted vocal strain) through use of modeling (“do what I do”) or tactile/visual cues</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Train speech enunciation that is within normal limits (i.e., no excessive movements) through use of modeling (“do what I do”) or tactile/visual cues</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Sensory calibration</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Focus attention on how it feels and sounds to talk with increased vocal loudness (self‐monitoring) and to internally cue (self‐generate) new loudness effort in speech</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Focus attention on how it feels and sounds to talk with increased enunciation (self‐monitoring) and to internally cue (self‐generate) new enunciation effort in speech</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">
                          <bold>Objective and subjective clinical data collected during each treatment session</bold>
                        </td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Measures of duration, frequency, and sound pressure level</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Measures of oral pressure and precise articulatory productions</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1">Documentation of percentage of cueing required to implement vocal loudness strategy</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Documentation of percentage of cueing required to implement enunciation strategy</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1">Observations of perceptual voice quality</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Observations of perceptual speech intelligibility</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant's self‐reported comments about successful use of the improved loudness in daily communication</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant's self‐reported comments about successful use of the improved enunciation in daily communication</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1"/>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant self‐reported perceived effort</td>
                        <td align="left" valign="top" rowspan="1" colspan="1">Participant self‐reported perceived effort</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="mds27460-note-0002">
                      <p>Both therapies are standardized with respect to intensive dosage. Effort in LSVT LOUD and LSVT ARTIC are based on the participant's self‐perceived effort during treatment tasks, on a scale of 1 to 10, with 10 being highest perceived effort.<xref rid="mds27460-bib-0087" ref-type="ref">87</xref>
</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
              </sec>
              <sec id="mds27460-sec-0013">
                <title>Control of Bias</title>
                <p>Clinicians were made aware that they could impart bias in this unblinded trial and focused their effort to deliver treatments with equipoise<xref rid="mds27460-bib-0124" ref-type="ref">124</xref> and reported they were equally invested in both treatments. In post‐treatment interviews, participants were asked their perception of whether their treatment was effective.<xref rid="mds27460-bib-0125" ref-type="ref">125</xref>
</p>
                <p>One and 7‐month data collection followed scripted protocols, and interview and experimental data were collected by trained research staff or clinicians. No clinician collected post‐treatment data from a participant he or she treated.</p>
              </sec>
              <sec id="mds27460-sec-0014">
                <title>Outcomes</title>
                <p>The primary outcome of SPL in reading and spontaneous speech is an objective, acoustic measure with established reliability in studies of PD.<xref rid="mds27460-bib-0008" ref-type="ref">8</xref> SPL would be expected to change as a result of driving increased amplitude of motor output across the speech mechanism through vocal or articulatory effort. The secondary outcome was a participant‐reported measure of communicative effectiveness (CETI‐M), which has demonstrated significant correlation with intelligibility<xref rid="mds27460-bib-0126" ref-type="ref">126</xref> and voice handicap,<xref rid="mds27460-bib-0127" ref-type="ref">127</xref> with established reliability for PD<xref rid="mds27460-bib-0127" ref-type="ref">127</xref>, <xref rid="mds27460-bib-0128" ref-type="ref">128</xref> (see Supporting Information). For both measures, the unit of analysis was change from baseline.</p>
              </sec>
              <sec id="mds27460-sec-0015">
                <title>Data Collection and Analysis</title>
                <sec id="mds27460-sec-0016">
                  <title>SPL</title>
                  <p>Data were collected by research staff on 2 separate days (days 1 and 2) within 1 week to allow assessment of test‐retest reliability at baseline, 1, and 7‐month time periods. Collection times were kept consistent for each participant. Participants were not cued to modify their speech (i.e., use loud or enunciate strategies) as per scripted protocol. Participants (1) read two standard passages (Rainbow and Hunter),<xref rid="mds27460-bib-0129" ref-type="ref">129</xref>, <xref rid="mds27460-bib-0130" ref-type="ref">130</xref> (2) described a picture (Picture),<xref rid="mds27460-bib-0131" ref-type="ref">131</xref> (3) spoke about a self‐selected topic for 1 minute (Monologue), (4) described an intensely happy event for 90 seconds (Happy Day),<xref rid="mds27460-bib-0132" ref-type="ref">132</xref> and (5) sustained six “ah” phonations for as long as possible (Ah). Data were collected in an IAC sound‐treated booth (IAC Acoustics, North Aurora, IL) using a head‐mounted AKG 420 condenser microphone positioned 8 cm from the lips. The microphone was calibrated to a Type I Sound Level Meter (SLM; Bruel and Kjaer 2238)<xref rid="mds27460-bib-0133" ref-type="ref">133</xref> to extract decibels (dB) of SPL.</p>
                  <p>The cleaned (e.g., edited of coughs), calibrated microphone signals were submitted to SPL analysis using a fully automated, custom‐built software program designed to emulate a Type I SLM resulting in a mean and standard deviation (SD) value for dB SPL at a reference distance of 30 cm.</p>
                </sec>
              </sec>
              <sec id="mds27460-sec-0017">
                <title>CETI‐M</title>
                <p>CETI‐M was collected at each time period with a minimum of 50% repeated for reliability purposes.<xref rid="mds27460-bib-0134" ref-type="ref">134</xref>
</p>
                <p>Participants rated their communicative effectiveness in 10 situations (e.g., “speaking to someone in a noisy environment”) on a 10‐point Likert scale, where 1 = not effective and 10 = extremely effective (see Supporting Information).</p>
              </sec>
              <sec id="mds27460-sec-0018">
                <title>Sample Size</title>
                <p>Based on previous studies,<xref rid="mds27460-bib-0087" ref-type="ref">87</xref>, <xref rid="mds27460-bib-0088" ref-type="ref">88</xref>, <xref rid="mds27460-bib-0089" ref-type="ref">89</xref>, <xref rid="mds27460-bib-0090" ref-type="ref">90</xref> the effect size for SPL was expected to be large (approximately 1). For an overall alpha = 0.05 considering three multiple comparisons (Bonferroni), two‐tailed tests, 20 participants were required per group to yield 80% power.<xref rid="mds27460-bib-0135" ref-type="ref">135</xref>
</p>
              </sec>
              <sec id="mds27460-sec-0019">
                <title>Statistical Analysis</title>
                <p>Descriptive statistics for SPL are presented as means and SDs, for CETI‐M as medians, interquartile ranges, and ranges, and for sex as relative frequencies. Before addressing hypotheses, test‐retest reliability (days 1 and 2) for SPL and CETI‐M was derived using intraclass correlation coefficients (ICCs) for baseline, 1‐month, and 7‐month measures.</p>
                <p>For Hypothesis 1 (baseline), to compare the combined group of all PD participants to HCs, <italic>t</italic>‐tests for independent samples were used for SPL and a Wilcoxon rank‐sum test was used for CETI‐M.</p>
                <p>For Hypothesis 2 (SPL), one‐way repeated‐measures analyses of variance with Duncan's multiple‐range tests were performed. Multiple imputation was not applied, but mixed‐effects models were used to support bivariate results with the assumption that the very few missing data values were missing completely at random.</p>
                <p>For Hypothesis 3 (CETI‐M), if any of the 10 CETI‐M items were missing, nonmissing items were prorated to obtain totals. Kruskal‐Wallis tests incorporated Bonferroni procedures to evaluate differences among PD groups for changes to 1 and 7 months.</p>
                <p>Within‐group changes from baseline were tested using mixed‐effects models for SPL and Wilcoxon signed‐rank tests for CETI‐M. ESs and 95% confidence intervals (CIs) were derived using Cohen's <italic>d</italic> for SPL. Analyses adhered to the intention‐to‐treat principle. All tests of hypotheses were two‐tailed, with an overall α‐level of 0.05. No subgroup analyses were conducted, no interim analysis was planned, and there was no data safety monitoring board.</p>
              </sec>
            </sec>
            <sec id="mds27460-sec-0020">
              <title>Results</title>
              <p>Of 106 individuals screened (81 PD, 25 HC), 64 PD and 20 HCs were enrolled (Fig. <xref rid="mds27460-fig-0001" ref-type="fig">1</xref>). Group assignments and descriptive statistics for baseline demographic characteristics and levodopa equivalence<xref rid="mds27460-bib-0136" ref-type="ref">136</xref> are presented in Table <xref rid="mds27460-tbl-0002" ref-type="table">2</xref>. There were no significant differences among the three PD treatment groups for these characteristics (<italic>P</italic> &gt; 0.05), and between the combined group of all PD participants and HC group for age and sex (<italic>P</italic> = 0.28; <italic>P</italic> = 0.75). No participants experienced serious adverse effects.</p>
              <table-wrap id="mds27460-tbl-0002" xml:lang="en" orientation="portrait" position="float">
                <label>Table 2</label>
                <caption>
                  <p>Demographic, baseline clinical characteristics, baseline SPL across tasks and baseline CETI‐M for participants by group</p>
                </caption>
                <table frame="hsides" rules="cols">
                  <col align="left" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <col align="center" span="1"/>
                  <thead valign="bottom">
                    <tr style="border-bottom:solid 1px #000000">
                      <th align="left" valign="bottom" rowspan="1" colspan="1">Demographics and Other Variables (Weights for Minimization)</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">PD Treated With LSVT LOUD (N = 22)</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">PD Treated With LSVT ARTIC (N = 20)</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">UNTXPD (N = 22)</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">All PD Combined (N = 64)</th>
                      <th align="center" valign="bottom" rowspan="1" colspan="1">HCs (N = 20)</th>
                    </tr>
                  </thead>
                  <tbody valign="top">
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Males (0.5)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">N</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">15</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">15</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">14</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">44</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">13</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">%</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">68.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">75.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">63.6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">68.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.0</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Females (0.5)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">N</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">20</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">7</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">%</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">31.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">25.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">36.4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">31.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">35.0</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Age (0.5)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">68</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">68</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">67</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">49,85</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">53,85</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">48,81</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">48,85</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">46,80</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Years since diagnosis (0.5)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.25,31</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,20</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.5,14</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,31</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Hoehn and Yahr stage with medication (0.5)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Swallow (1)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.3</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,2</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Voice (1)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.6</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,2</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Articulation (1)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.1</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.2</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,1</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">BDI‐II (0.25)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">10</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,20</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,20</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1,21</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,21</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,13</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">MMSE (0.25)</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">29</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0.9</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">26,30</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">27,30</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">27,30</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">26,30</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">27,30</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Levodopa equivalent medication, (mg/d)</td>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                      <td align="left" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">689</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">718</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">726</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">711</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">486</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">510</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">404</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">460</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">—</td>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">30,2064</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,1773</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">100,1400</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">0,2064</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <td align="left" valign="top" rowspan="1" colspan="1">Baseline SPL Measures by Task,<break/>
(dB at 30 cm)
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">PD Treated With LSVT LOUD<break/>
(N = 22)
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">PD Treated With LSVT ARTIC<break/>
(N = 20)
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">UNTXPD<break/>
(N = 22)
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">All PD Combined<break/>
(N = 64)
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">HCs<break/>
(N = 20)
</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Rainbow</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">71.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">71.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">72.6</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.1</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.5,76.6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">66.8,76.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.1,77.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.5,77.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">68.6,75.5</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Hunter</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">71.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">72.7</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.0</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.4,75.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.2,79.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.0,76.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.4,79.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">68.7,76.8</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Picture</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">69.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">69.6</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">69.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">71.3</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.4</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">62.5,73.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.2,79.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.7,75.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">62.5,79.5</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">66.5,76.3</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Conversation</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">69.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">69.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">71.5</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.2</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.1,73.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.0,79.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.7,75.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.1,79.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">66.9,76.2</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Happy</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">71.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">70.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">72.5</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.8</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">3.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">2.8</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.9,75.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.6,81.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.3,76.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64.6,81.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.8,77.6</td>
                    </tr>
                    <tr>
                      <td align="left" valign="top" rowspan="1" colspan="1">Ah</td>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                      <td align="center" valign="top" rowspan="1" colspan="1"/>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Mean</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">75.0</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">73.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">76.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">74.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">76.6</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">SD</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5.4</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.7</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">5.2</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">4.6</td>
                    </tr>
                    <tr style="border-bottom:solid 1px #000000">
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">62.8,83.9</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">65.5,81.3</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">67.4,87.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">62.8,87.1</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">67.6,82.9</td>
                    </tr>
                    <tr>
                      <td colspan="6" align="left" valign="top" rowspan="1">Baseline total CETI‐M</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Median</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">64</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">58</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">61</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">62</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">84</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">26,100</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">28,86</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">14,98</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">14,100</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">62,100</td>
                    </tr>
                    <tr>
                      <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">IQR<xref ref-type="fn" rid="mds27460-note-0007">1</xref>
</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">57,77</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">48,75</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">54,73</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">53,76</td>
                      <td align="center" valign="top" rowspan="1" colspan="1">76,90</td>
                    </tr>
                  </tbody>
                </table>
                <table-wrap-foot>
                  <fn id="mds27460-note-0003">
                    <p>Voice and Articulation were measured on a scale from 0 to 5, where 0 = no disorder and 5 = severe disorder (see Supporting Information). Randomization ratio was 1:1:1 performed using a minimization program based on variables and weights chosen <italic>a priori</italic>.</p>
                  </fn>
                  <fn id="mds27460-note-0004">
                    <p>Rainbow, Hunter, Picture, Conversation, Happy, and Ah refer to speech tasks described in Materials and Methods.</p>
                  </fn>
                  <fn id="mds27460-note-0005">
                    <p>There were significant differences between HCs and combined PD groups for depression, swallowing, voice, and articulation (<italic>P</italic> &lt; 0.0001), with PD participants exhibiting less optimal characteristics. Significance levels of differences for SPL are presented for Hypothesis 2 in the Results section.</p>
                  </fn>
                  <fn id="mds27460-note-0006">
                    <p>Total CETI‐M score was derived by adding all item scores ranging from 10 (never effective in any situation) to 100 (extremely effective in all situations) and prorated as per Materials and Methods.</p>
                  </fn>
                  <fn id="mds27460-note-0007">
                    <label>1</label>
                    <p>IQR is the interquartile range from the 25th to the 75th percentile. Median for changes is the median of within‐subject changes from baseline to subsequent time point.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <sec id="mds27460-sec-0021">
                <title>Reliability</title>
                <p>ICCs for test‐retest reliability (days 1 and 2) were &gt;0.80 at baseline, 1 and 7 months for both SPL and CETI‐M. To avoid bias attributed to practice effects, day 1 measures were chosen for statistical analysis.</p>
              </sec>
              <sec id="mds27460-sec-0022">
                <title>Hypothesis 1</title>
                <p>The combined group of all PD participants had significantly lower (less optimal) SPL values at baseline than the HC group (Table <xref rid="mds27460-tbl-0002" ref-type="table">2</xref>) for Rainbow (<italic>P</italic> = 0.04), Hunter (<italic>P</italic> = 0.01), Conversation (<italic>P</italic> = 0.04), and Happy Day (<italic>P</italic> = 0.03); differences were not significant for Picture (<italic>P</italic> = 0.06) and Ah (<italic>P</italic> = 0.18). Median baseline CETI‐M for the PD combined group differed significantly from HCs (<italic>P</italic> &lt; 0.0001), with PD participants having less optimal scores.</p>
              </sec>
              <sec id="mds27460-sec-0023">
                <title>Hypothesis 2</title>
                <p>Descriptive statistics for between and within‐group changes in SPL from baseline to 1 and 7 months for each PD group, and corresponding ESs and 95% CIs are presented in Table <xref rid="mds27460-tbl-0003" ref-type="table">3</xref>.</p>
                <table-wrap id="mds27460-tbl-0003" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 3</label>
                  <caption>
                    <p>Descriptive statistics for changes in dB SPL at 30 cm from baseline to 1 and 7 months, ESs, and corresponding 95% CIs for all speech tasks by PD group and pair‐wise group comparisons</p>
                  </caption>
                  <table frame="hsides" rules="cols">
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th colspan="10" align="center" valign="bottom" rowspan="1">Change From Baseline to 1 month</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th style="border-bottom:solid 1px #000000" align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <th colspan="2" align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">LSVT LOUD (N = 22)</th>
                        <th colspan="2" align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">LSVT ARTIC (N = 20)</th>
                        <th colspan="2" align="center" style="border-bottom:solid 1px #000000" valign="bottom" rowspan="1">UNTXPD (N = 22)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT‐L V.<break/>
UNTXD
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT‐A V. UNTXD</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT‐L V.<break/>
LSVT‐A
</th>
                      </tr>
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Mean<break/>
[WES<xref ref-type="fn" rid="mds27460-note-0008">a</xref>]
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">SD<break/>
[WESCI<xref ref-type="fn" rid="mds27460-note-0009">b</xref>]
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Mean<break/>
[WES<xref ref-type="fn" rid="mds27460-note-0008">a</xref>]
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">SD<break/>
[WESCI<xref ref-type="fn" rid="mds27460-note-0009">b</xref>]
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">Mean<break/>
[WES<xref ref-type="fn" rid="mds27460-note-0008">a</xref>]
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">SD<break/>
[WESCI<xref ref-type="fn" rid="mds27460-note-0009">b</xref>]
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">BES<break/>
[BESCI]<xref ref-type="fn" rid="mds27460-note-0010">c</xref>
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">BES<break/>
[BESCI]<xref ref-type="fn" rid="mds27460-note-0010">c</xref>
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">BES<break/>
[BESCI]<xref ref-type="fn" rid="mds27460-note-0010">c</xref>
</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Rainbow</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">6.3<break/>
[2.13]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.1<break/>
[1.55, 2.59]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.3<break/>
[0.62]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.2<break/>
[0.14, 1.10]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.5<break/>
[0.31]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.7<break/>
[–0.14, 0.77]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.32<break/>
[1.52, 3.04]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.41<break/>
[–0.21, 1.01]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.84<break/>
[1.09, 2.53]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Hunter</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">6.4<break/>
[2.31]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.9<break/>
[1.71, 2.81]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.4<break/>
[0.67]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.2<break/>
[0.18, 1.15]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.4<break/>
[0.25]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.7<break/>
[–0.20, 0.70]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.52<break/>
[1.69, 3.26]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.51<break/>
[–0.11, 1.12]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.93<break/>
[1.16, 2.62]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Picture</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">5.3<break/>
[2.06]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.7<break/>
[1.47, 2.56]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.4<break/>
[0.53]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.8<break/>
[0.05, 0.98]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.2<break/>
[0.11]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.9<break/>
[–0.33, 0.55]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.18<break/>
[1.40, 2.89]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.51<break/>
[–0.12, 1.11]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.42<break/>
[0.72, 2.07]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Monologue</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">5.2<break/>
[1.70]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.2<break/>
[1.17, 2.14]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.0<break/>
[0.48]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.2<break/>
[0.00, 0.95]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.3<break/>
[0.20]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.6<break/>
[–0.25, 0.65]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.94<break/>
[1.19, 2.61]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.37<break/>
[–0.25, 0.97]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.52<break/>
[0.8, 2.17]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Happy</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.7<break/>
[1.49]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.6<break/>
[0.96, 1.96]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–0.0<break/>
[0.00]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.5<break/>
[–0.46, 0.46]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–0.7<break/>
[–0.41]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.8<break/>
[–0.87, 0.04]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.97<break/>
[1.22, 2.65]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.32<break/>
[–0.30, 0.92]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.45<break/>
[0.75, 2.10]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Ah</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">9.3<break/>
[1.88]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">5.2<break/>
[1.34, 2.26]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.0<break/>
[0.50]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">4.2<break/>
[0.02, 0.94]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–0.2<break/>
[–0.07]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.2<break/>
[–0.50, 0.37]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.20<break/>
[1.42, 2.90]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.59<break/>
[–0.04, 1.20]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.54<break/>
[0.82, 2.19]
</td>
                      </tr>
                    </tbody>
                  </table>
                  <table frame="hsides" rules="cols">
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead valign="bottom">
                      <tr>
                        <th colspan="10" align="center" valign="bottom" rowspan="1">Change From Baseline to 7 Months</th>
                      </tr>
                      <tr>
                        <th align="left" valign="bottom" rowspan="1" colspan="1"/>
                        <th colspan="2" align="center" valign="bottom" rowspan="1">LSVT LOUD (N = 21)</th>
                        <th colspan="2" align="center" valign="bottom" rowspan="1">LSVT ARTIC (N = 19)</th>
                        <th colspan="2" align="center" valign="bottom" rowspan="1">UNTXPD (N = 20)</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT‐L V.<break/>
UNTXD
</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT‐A V. UNTXD</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">LSVT‐L V.<break/>
LSVT‐A
</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Rainbow</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.9<break/>
[1.78]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.3<break/>
[1.20, 2.32]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.7<break/>
[0.34]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.2<break/>
[–0.15, 0.81]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.3<break/>
[0.17]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.9<break/>
[–0.30, 0.64]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.70<break/>
[0.96, 2.38]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.19<break/>
[–0.44, 0.82]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.42<break/>
[0.70, 2.08]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Hunter</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.8<break/>
[1.90]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.1<break/>
[1.29, 2.49]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.8<break/>
[0.38]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.2<break/>
[–0.10, 0.86]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.3<break/>
[0.14]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.2<break/>
[–0.32, 0.61]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.63<break/>
[0.89, 2.30]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.23<break/>
[–0.41, 0.85]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.40<break/>
[0.68, 2.06]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Picture</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.2<break/>
[1.46]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.3<break/>
[0.92, 1.97]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.7<break/>
[0.32]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.3<break/>
[–0.16, 0.80]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.4<break/>
[0.20]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.1<break/>
[–0.27, 0.67]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.27<break/>
[0.58, 1.91]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.14<break/>
[–0.49, 0.76]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.09<break/>
[0.40, 1.73]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Monologue</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.9<break/>
[1.69]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.8<break/>
[1.09, 2.33]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.6<break/>
[0.35]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.8<break/>
[–0.13, 0.85]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.5<break/>
[0.29]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.8<break/>
[–0.27, 0.67]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.33<break/>
[0.63, 1.98]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.06<break/>
[–0.57, 0.68]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.28<break/>
[0.57, 1.93]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Happy</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.9<break/>
[1.00]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.0<break/>
[0.50, 1.50]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–0.7<break/>
[–0.30]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.5<break/>
[–0.77, 0.19]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–0.8<break/>
[–0.34]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2.5<break/>
[–0.18, 0.77]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.20<break/>
[0.51, 1.84]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.04<break/>
[–0.59, 0.67]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.16<break/>
[0.46, 1.80]
</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Ah</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">8.2<break/>
[1.96]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">4.4<break/>
[1.40, 2.36]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.8<break/>
[0.25]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3.4<break/>
[–0.23, 0.71]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–0.4<break/>
[–0.09]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">4.7<break/>
[–0.80, 0.13]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.89<break/>
[1.12, 2.59]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0.29<break/>
[–0.35, 0.92]
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1.87<break/>
[1.09, 2.57]
</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="mds27460-note-0008">
                      <label>a</label>
                      <p>WES is the within group change effect size using Cohen's <italic>d</italic>.</p>
                    </fn>
                    <fn id="mds27460-note-0009">
                      <label>b</label>
                      <p>WESCI is the 95% confidence interval for the within‐group change effect size from Cohen's <italic>d</italic>.</p>
                    </fn>
                    <fn id="mds27460-note-0010">
                      <label>c</label>
                      <p>BES is the between‐group effect size using Cohen's <italic>d</italic> and corresponding 95% confidence intervals [BESCI] for differences; <italic>P</italic> values from mixed‐effects model for differences in trends across groups were significant for all tasks at <italic>P</italic> &lt; 0.0001.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>Between‐group increases from baseline to 1 and 7 months in SPL following LSVT LOUD were significantly larger than those for both LSVT ARTIC and UNTXPD for Rainbow, Hunter, Picture, Monologue, Happy Day, and Ah (<italic>P</italic> &lt; 0.05; <italic>P</italic> &lt; 0.05). There were no significant differences between LSVT ARTIC and UNTXPD (<italic>P</italic> &gt; 0.05). Within‐group changes from baseline to 1 and 7 months were significant for all tasks following LSVT LOUD (<italic>P</italic> &lt; 0.05). Within‐group changes in SPL for LSVT ARTIC were significant at 1 month for all tasks (<italic>P</italic> &lt; 0.05) except for Happy Day (<italic>P</italic> = 0.65) and not significant for any task at 7 months (<italic>P</italic> &gt; 0.09). Within‐group changes in SPL at 1 and 7 months for UNTXPD were not significant for any task (<italic>P</italic> &gt; 0.15). SPL Monologue data are plotted in Figure <xref rid="mds27460-fig-0002" ref-type="fig">2</xref>A.</p>
                <fig fig-type="Figure" xml:lang="en" id="mds27460-fig-0002" orientation="portrait" position="float">
                  <label>Figure 2</label>
                  <caption>
                    <p>(A) Means and SDs for dB of SPL at 30 cm for LSVT LOUD, LSVT ARTIC, and UNTXPD at baseline, 1, and 7 months. The monologue task was plotted as most representative of spontaneous speech. (B) Medians and interquartile ranges from the 25th to the 75th percentile for the CETI‐M scaled 0 to 100 for LSVT LOUD, LSVT ARTIC, and UNTXPD at baseline, 1, and 7 months.</p>
                  </caption>
                  <graphic id="nlm-graphic-3" xlink:href="MDS-33-1777-g002"/>
                </fig>
              </sec>
              <sec id="mds27460-sec-0024">
                <title>Hypothesis 3</title>
                <p>Descriptive statistics for between and within‐group changes in CETI‐M from baseline to 1 and 7 months for each PD group are presented in Table <xref rid="mds27460-tbl-0004" ref-type="table">4</xref>.</p>
                <table-wrap id="mds27460-tbl-0004" xml:lang="en" orientation="portrait" position="float">
                  <label>Table 4</label>
                  <caption>
                    <p>Descriptive statistics for changes in CETI‐M from baseline to 1 and 7 months</p>
                  </caption>
                  <table frame="hsides" rules="cols">
                    <col align="left" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <col align="center" span="1"/>
                    <thead valign="bottom">
                      <tr style="border-bottom:solid 1px #000000">
                        <th align="left" valign="bottom" rowspan="1" colspan="1">CETI‐M</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">PD Treated With LSVT LOUD</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">PD Treated With LSVT ARTIC</th>
                        <th align="center" valign="bottom" rowspan="1" colspan="1">UNTXPD</th>
                      </tr>
                    </thead>
                    <tbody valign="top">
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Change from baseline to 1 month</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">(n = 22)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">(n = 20)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">(n = 22)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Median<xref ref-type="fn" rid="mds27460-note-0012">a</xref>
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">13</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">9</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–12,36</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–4,39</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–16,23</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">IQR<xref ref-type="fn" rid="mds27460-note-0013">b</xref>
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">0,21</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">3,23</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–10,9</td>
                      </tr>
                      <tr>
                        <td align="left" valign="top" rowspan="1" colspan="1">Change from baseline to 7 months</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">(n = 21)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">(n = 19)</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">(n = 20)</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Median<xref ref-type="fn" rid="mds27460-note-0012">a</xref>
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">8</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">1</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">4.5</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">Range</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–18,31</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–12,24</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–23,20</td>
                      </tr>
                      <tr>
                        <td style="padding-left:10%" align="left" valign="top" rowspan="1" colspan="1">IQR<xref ref-type="fn" rid="mds27460-note-0012">a</xref>
</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">2,15</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–3,7</td>
                        <td align="center" valign="top" rowspan="1" colspan="1">–10,11</td>
                      </tr>
                    </tbody>
                  </table>
                  <table-wrap-foot>
                    <fn id="mds27460-note-0011">
                      <p>Total CETI‐M score was derived by adding all item scores ranging from 10 (never effective in any situation) to 100 (extremely effective in all situations) and prorated as per Materials and Methods.</p>
                    </fn>
                    <fn id="mds27460-note-0012">
                      <label>a</label>
                      <p>Median for changes is the median of within‐group subject changes from baseline to subsequent time point.</p>
                    </fn>
                    <fn id="mds27460-note-0013">
                      <label>b</label>
                      <p>IQR is the interquartile range from the 25th to the 75th percentile.</p>
                    </fn>
                  </table-wrap-foot>
                </table-wrap>
                <p>There were significant between‐group differences for CETI‐M change from baseline to 1 month indicating greater improvement for LSVT LOUD and LSVT ARTIC relative to UNTXPD (<italic>P</italic> = 0.02; <italic>P</italic> = 0.02). Between‐group differences for CETI‐M change from baseline to 7 months for LSVT LOUD and LSVT ARTIC versus UNTXPD groups were not significant (<italic>P</italic> = 0.08).</p>
                <p>Within‐group changes in CETI‐M scores from baseline to 1 month were significant for LSVT LOUD (<italic>P</italic> = 0.0005) and LSVT ARTIC (<italic>P</italic> = 0.0001), with no significant changes in the UNTXPD group (<italic>P</italic> = 0.65). Within‐group CETI‐M changes from baseline to 7 months were significant for LSVT LOUD (<italic>P</italic> = 0.0011), but not for LSVT ARTIC (<italic>P</italic> = 0.27) or UNTXPD (<italic>P</italic> = 0.73). CETI‐M data are plotted in Figure <xref rid="mds27460-fig-0002" ref-type="fig">2</xref>B.</p>
                <p>At the end of the study, LSVT LOUD and LSVT ARTIC participants were asked, “Out of all the treatment groups you could have been randomized into, do you feel you had the best treatment?”<xref rid="mds27460-bib-0125" ref-type="ref">125</xref> Positive responses were comparable between groups (100% vs. 95%, respectively).</p>
              </sec>
            </sec>
            <sec id="mds27460-sec-0025">
              <title>Discussion</title>
              <p>This RCT evaluated the impact of two speech treatments for PD matched in intensive dosage, differing in speech target: <italic>voice</italic> (respiratory‐laryngeal/LSVT LOUD) versus <italic>articulation</italic> (orofacial‐articulatory/LSVT ARTIC), relative to untreated controls.</p>
              <p>Regarding Hypothesis 1, significant differences in SPL and CETI‐M were found at baseline between the combined group of all PD participants and the HC group. The finding that SPL was significantly lower in the PD than the HC group is consistent with previous reports of reduced loudness in PD<xref rid="mds27460-bib-0008" ref-type="ref">8</xref>, <xref rid="mds27460-bib-0014" ref-type="ref">14</xref>, <xref rid="mds27460-bib-0023" ref-type="ref">23</xref> and reduced communicative effectiveness and participation.<xref rid="mds27460-bib-0008" ref-type="ref">8</xref>
</p>
              <p>Regarding Hypothesis 2, there were significant differences among LSVT LOUD, LSVT ARTIC, and UNTXPD in SPL over 7 months. Increases in SPL were significantly greater for the <italic>voice</italic> versus <italic>articulation</italic> target and were maintained through 7 months only for the target of <italic>voice</italic>. This magnitude of increase in SPL is both statistically and clinically significant, having an impact on improving audibility<xref rid="mds27460-bib-0008" ref-type="ref">8</xref>, <xref rid="mds27460-bib-0137" ref-type="ref">137</xref> in a population that struggles with “weak voice.”<xref rid="mds27460-bib-0001" ref-type="ref">1</xref>, <xref rid="mds27460-bib-0005" ref-type="ref">5</xref>, <xref rid="mds27460-bib-0006" ref-type="ref">6</xref>, <xref rid="mds27460-bib-0007" ref-type="ref">7</xref>, <xref rid="mds27460-bib-0014" ref-type="ref">14</xref>, <xref rid="mds27460-bib-0039" ref-type="ref">39</xref> The absence of adverse side effects is consistent with previous studies demonstrating that increased SPL can be accompanied by improved vocal fold closure and voice quality without inducing laryngeal hyperfunction post LSVT LOUD.<xref rid="mds27460-bib-0009" ref-type="ref">9</xref>, <xref rid="mds27460-bib-0138" ref-type="ref">138</xref>
</p>
              <p>These findings extend our previous research<xref rid="mds27460-bib-0087" ref-type="ref">87</xref>, <xref rid="mds27460-bib-0088" ref-type="ref">88</xref>, <xref rid="mds27460-bib-0089" ref-type="ref">89</xref>, <xref rid="mds27460-bib-0090" ref-type="ref">90</xref> by including both an alternative treatment target and untreated control groups. The current findings, that improvements following <italic>voice</italic> treatment exceeded those following <italic>articulation</italic> (ES = 1.53) and no treatment (ES = 2.19), together with those of two earlier RCTs<xref rid="mds27460-bib-0089" ref-type="ref">89</xref>, <xref rid="mds27460-bib-0090" ref-type="ref">90</xref> (ES = 0.65–2.03), build solid evidence for the efficacy of intensive treatment targeting <italic>voice</italic> for improving speech in PD.</p>
              <p>One explanation for these findings comes from our PET imaging studies. In addition to observing treatment‐related modification of neural systems involved in vocalization, a rightward shift of activation in speech motor control and prefrontal and auditory areas<xref rid="mds27460-bib-0139" ref-type="ref">139</xref>, <xref rid="mds27460-bib-0140" ref-type="ref">140</xref> has been observed post‐LSVT LOUD and not post‐LSVT ARTIC.<xref rid="mds27460-bib-0141" ref-type="ref">141</xref>, <xref rid="mds27460-bib-0142" ref-type="ref">142</xref>
</p>
              <p>Regarding Hypothesis 3, there were significant differences among LSVT LOUD, LSVT ARTIC, and UNTXPD in CETI‐M immediately post‐treatment with relative improvements for both intensive treatment targets. Improvements in CETI‐M were maintained through 7 months only for LSVT LOUD, suggesting that greater SPL improvement from the voice target may impact self‐rated communication situations such as speaking in noise.<xref rid="mds27460-bib-0128" ref-type="ref">128</xref>
</p>
              <sec id="mds27460-sec-0026">
                <title>Limitations and Clinical Implications</title>
                <p>Although findings from this third RCT reduce the critical gap in our knowledge of speech treatment in PD, there are limitations.</p>
                <p>The RCT was powered based upon previous evidence to detect an effect in the primary outcome SPL. Although the resulting sample size is consistent with behavioral treatment studies,<xref rid="mds27460-bib-0143" ref-type="ref">143</xref> it precluded using multivariate statistics. However, we did find significant differences in between‐ and within‐group changes over time. Additionally, although we used multiple comparison procedures for the power analysis and to control for inflation of type 1 errors for three pair‐wise comparisons, we did not adjust for multiple outcomes for SPL.</p>
                <p>Whereas PD participants ranged in disease severity and age, generally they had mild‐moderate disease. Nevertheless, it was demonstrated that their speech characteristics and self‐evaluation of communicative effectiveness were significantly worse than those of the HC group at baseline, consistent with reports of speech disorders occurring early and throughout the course of PD.<xref rid="mds27460-bib-0001" ref-type="ref">1</xref>, <xref rid="mds27460-bib-0006" ref-type="ref">6</xref>, <xref rid="mds27460-bib-0007" ref-type="ref">7</xref>, <xref rid="mds27460-bib-0014" ref-type="ref">14</xref>, <xref rid="mds27460-bib-0039" ref-type="ref">39</xref> Treating speech disorders in mild‐moderate PD may help maintain functional communication and quality of life,<xref rid="mds27460-bib-0004" ref-type="ref">4</xref>, <xref rid="mds27460-bib-0005" ref-type="ref">5</xref>, <xref rid="mds27460-bib-0031" ref-type="ref">31</xref>, <xref rid="mds27460-bib-0039" ref-type="ref">39</xref> which is in accord with rehabilitation literature supporting ongoing exercise in mild‐moderate PD.<xref rid="mds27460-bib-0085" ref-type="ref">85</xref>, <xref rid="mds27460-bib-0144" ref-type="ref">144</xref>
</p>
                <p>The ability to generalize these findings to patients with more advanced disease is supported by our finding of no significant associations between time postdiagnosis (ranging 0–31 years) and within‐group treatment‐related changes in SPL through 7 months (<italic>P</italic> = 0.30). This suggests that regardless of disease severity, participants showed similar treatment‐related improvements within‐group. This observation is consistent with our previous RCTs<xref rid="mds27460-bib-0087" ref-type="ref">87</xref>, <xref rid="mds27460-bib-0088" ref-type="ref">88</xref>, <xref rid="mds27460-bib-0089" ref-type="ref">89</xref>, <xref rid="mds27460-bib-0090" ref-type="ref">90</xref> reporting successful outcomes following LSVT LOUD with more advanced patients including those with atypical PD and post‐DBS‐STN.<xref rid="mds27460-bib-0145" ref-type="ref">145</xref>, <xref rid="mds27460-bib-0146" ref-type="ref">146</xref>, <xref rid="mds27460-bib-0147" ref-type="ref">147</xref>, <xref rid="mds27460-bib-0148" ref-type="ref">148</xref>
</p>
                <p>Given that these results emerged from an RCT framework, generalization to “real‐world” situations may be questioned. However, positive outcomes of similar magnitude have been reported following LSVT LOUD by independent researchers globally<xref rid="mds27460-bib-0149" ref-type="ref">149</xref>, <xref rid="mds27460-bib-0150" ref-type="ref">150</xref>, <xref rid="mds27460-bib-0151" ref-type="ref">151</xref>, <xref rid="mds27460-bib-0152" ref-type="ref">152</xref>, <xref rid="mds27460-bib-0153" ref-type="ref">153</xref>, <xref rid="mds27460-bib-0154" ref-type="ref">154</xref>, <xref rid="mds27460-bib-0155" ref-type="ref">155</xref>, <xref rid="mds27460-bib-0156" ref-type="ref">156</xref>, <xref rid="mds27460-bib-0157" ref-type="ref">157</xref> and by thousands of clinicians worldwide<xref rid="mds27460-bib-0158" ref-type="ref">158</xref> trained in LSVT LOUD for implementation in clinical practice.<xref rid="mds27460-bib-0005" ref-type="ref">5</xref>, <xref rid="mds27460-bib-0159" ref-type="ref">159</xref>
</p>
                <p>We did not use a sham treatment to control the effect of differential attention.<xref rid="mds27460-bib-0160" ref-type="ref">160</xref> However, given the limitations of shams as appropriate comparators in behavioral treatment studies<xref rid="mds27460-bib-0107" ref-type="ref">107</xref> and because our RCT was designed to compare two treatments matched in attention, we determined that an untreated control group provided a more useful contrast.</p>
                <p>Because this is a behavioral intervention trial, neither clinicians providing treatment nor participants could be blinded. However, great care was taken to evaluate reliability, ensure equipoise, implement standardized training, minimize bias in data collection and analysis, and maintain independence between treating clinicians and those recording data. The finding that participants in both treatment groups perceived they received the most effective treatment supports that treatment delivery was similar across the two approaches and that related attempts to minimize bias were successful.</p>
                <p>The choice of the primary outcome of SPL may have been biased inherently towards the <italic>voice</italic> treatment group. However, previous studies of stimulating <italic>articulation</italic>
<xref rid="mds27460-bib-0023" ref-type="ref">23</xref>, <xref rid="mds27460-bib-0161" ref-type="ref">161</xref> (versus treating) have documented an immediate increase in SPL. The current study is the first to intensively treat <italic>articulatory</italic> effort and measure its impact on SPL and communicative effectiveness. Although there were no between‐group improvements in SPL for LSVT ARTIC at 1 or 7 months, there was a small, but significant, within‐group change at 1 month suggesting an effect on articulatory/vocal linkages,<xref rid="mds27460-bib-0095" ref-type="ref">95</xref>, <xref rid="mds27460-bib-0161" ref-type="ref">161</xref> supporting the selection of <italic>articulation</italic> as an appropriate treatment target comparator.</p>
                <p>Ongoing analyses of speech intelligibility,<xref rid="mds27460-bib-0162" ref-type="ref">162</xref> voice quality,<xref rid="mds27460-bib-0163" ref-type="ref">163</xref> swallowing,<xref rid="mds27460-bib-0164" ref-type="ref">164</xref> facial expression,<xref rid="mds27460-bib-0165" ref-type="ref">165</xref> and imaging (PET)<xref rid="mds27460-bib-0141" ref-type="ref">141</xref>, <xref rid="mds27460-bib-0142" ref-type="ref">142</xref> in these participants will further clarify mechanisms of response to these speech treatment targets in PD.</p>
              </sec>
            </sec>
            <sec id="mds27460-sec-0027">
              <title>Conclusions</title>
              <p>This RCT contributes to closing the knowledge gap on effective speech treatments for PD.<xref rid="mds27460-bib-0108" ref-type="ref">108</xref>, <xref rid="mds27460-bib-0109" ref-type="ref">109</xref> It provides additional support for <italic>voice</italic> (LSVT LOUD) as an efficacious target when delivered intensively in the treatment of speech in PD with outcomes sustained through 7 months for both objective (SPL) and participant‐reported (CETI‐M) measures. These findings suggest that the treatment target of <italic>voice</italic> may be uniquely beneficial in improving speech production in PD.</p>
            </sec>
            <sec sec-type="note-added-in-proof" id="mds27460-sec-0029">
              <title>Author Roles</title>
              <p>(1) Research Project: A. Conception, B. Organization, C. Execution; (2) Statistical Analysis: A. Design, B. Execution, C. Review and Critique; (3) Manuscript Preparation: A. Writing of the First Draft, B. Review and Critique.</p>
              <p>L.R.: 1A, 1B, 1C, 3A, 3B</p>
              <p>K.F.: 2B, 2C, 3A, 3B</p>
              <p>A.H.: 1A, 1B, 1C, 3B</p>
              <p>J.S.: 1A, 1B, 1C, 3B</p>
              <p>C.F.: 1A, 1B, 1C, 3B</p>
            </sec>
            <sec sec-type="note-added-in-proof" id="mds27460-sec-0030">
              <title>Data Access and Responsibility</title>
              <p>Katherine Freeman takes responsibility for the accuracy of the statistical analyses.</p>
            </sec>
            <sec sec-type="COI-statement" id="mds27460-sec-0031">
              <title>Financial Disclosures</title>
              <p>See relevant conflicts of interest/financial disclosures.</p>
            </sec>
            <sec sec-type="note-added-in-proof" id="mds27460-sec-0032">
              <title>Funding agencies</title>
              <p>National Institutes of Health‐National Institute of Deafness and Other Communication Disorders (NIH‐NIDCD) R01 DC01150 and LSVT Global, Inc., Tucson, Arizona, USA.</p>
            </sec>
            <sec sec-type="COI-statement" id="mds27460-sec-0033">
              <title>Relevant conflicts of interest/financial disclosures</title>
              <p>Throughout the active phase of the study, funding was provided by The National Institutes of Health‐National Institute for Deafness and other Communication Disorders (NIH‐NIDCD) (R01 DC01150) through the University of Colorado‐Boulder/National Center for Voice and Speech, the primary place of employment for Ramig (Full Professor), Halpern, and Spielman, and where Fox was a consultant. Freeman was a Full Professor at Albert Einstein College of Medicine, Bronx, New York, USA. During poststudy data analysis and manuscript preparation, Ramig, Halpern, and Fox have had employment roles with LSVT Global, and Spielman and Freeman have been paid consultants. Full financial disclosures can be found in the online version of the article.</p>
            </sec>
            <sec sec-type="supplementary-material">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="mds27460-supitem-0001">
                <caption>
                  <p><bold>Appendix S1</bold>: Supporting Information.</p>
                </caption>
                <media xlink:href="MDS-33-1777-s001.docx">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ack id="mds27460-sec-0028">
              <title>Acknowledgments</title>
              <p>We are grateful to our patients who continually provide our inspiration. We thank Phillip Gilley, PhD, for his help with randomization and Jill Petska and Ona Reed for their assistance.</p>
            </ack>
            <ref-list id="mds27460-bibl-0001" content-type="cited-references">
              <title>References</title>
              <ref id="mds27460-bib-0001">
                <label>1</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0001"><string-name><surname>Logemann</surname><given-names>JA</given-names></string-name>, <string-name><surname>Fisher</surname><given-names>HB</given-names></string-name>, <string-name><surname>Boshes</surname><given-names>B</given-names></string-name>, <string-name><surname>Blonsky</surname><given-names>ER</given-names></string-name>. <article-title>Frequency and cooccurrence of vocal tract dysfunctions in the speech of a large sample of Parkinson patients</article-title>. <source xml:lang="en">J Speech Hear Disord</source><year>1978</year>;<volume>43</volume>:<fpage>47</fpage>–<lpage>57</lpage>.<pub-id pub-id-type="pmid">633872</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0002">
                <label>2</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0002"><string-name><surname>Hartelius</surname><given-names>L</given-names></string-name>, <string-name><surname>Svensson</surname><given-names>P</given-names></string-name>. <article-title>Speech and swallowing symptoms associated with Parkinson's disease and multiple sclerosis: a survey</article-title>. <source xml:lang="en">Folia Phoniatr Logop</source><year>1994</year>;<volume>46</volume>:<fpage>9</fpage>–<lpage>17</lpage>.<pub-id pub-id-type="pmid">8162135</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0003">
                <label>3</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0003"><string-name><surname>Ho</surname><given-names>AK</given-names></string-name>, <string-name><surname>Iansek</surname><given-names>R</given-names></string-name>, <string-name><surname>Marigliani</surname><given-names>C</given-names></string-name>, <string-name><surname>Bradshaw</surname><given-names>JL</given-names></string-name>, <string-name><surname>Gates</surname><given-names>S</given-names></string-name>. <article-title>Speech impairment in a large sample of patients with Parkinson's disease</article-title>. <source xml:lang="en">Behav Neurol</source><year>1998</year>;<volume>11</volume>:<fpage>131</fpage>–<lpage>137</lpage>.<pub-id pub-id-type="pmid">11568413</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0004">
                <label>4</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0004"><string-name><surname>Miller</surname><given-names>N</given-names></string-name>, <string-name><surname>Allcock</surname><given-names>L</given-names></string-name>, <string-name><surname>Jones</surname><given-names>D</given-names></string-name>, <string-name><surname>Noble</surname><given-names>E</given-names></string-name>, <string-name><surname>Hildreth</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Burn</surname><given-names>DJ</given-names></string-name>. <article-title>Prevalence and pattern of perceived intelligibility changes in Parkinson's disease</article-title>. <source xml:lang="en">J Neurol Neurosurg Psychiatry</source><year>2007</year>;<volume>78</volume>:<fpage>1188</fpage>–<lpage>1190</lpage>.<pub-id pub-id-type="pmid">17400592</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0005">
                <label>5</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0005"><string-name><surname>Schalling</surname><given-names>E</given-names></string-name>, <string-name><surname>Johansson</surname><given-names>K</given-names></string-name>, <string-name><surname>Hartelius</surname><given-names>L</given-names></string-name>. <article-title>Speech and communication changes reported by people with Parkinson's disease</article-title>. <source xml:lang="en">Folia Phoniatr Logop</source><year>2017</year>;<volume>69</volume>:<fpage>131</fpage>–<lpage>141</lpage>.<pub-id pub-id-type="pmid">29346787</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0006">
                <label>6</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0006"><string-name><surname>Darley</surname><given-names>FL</given-names></string-name>, <string-name><surname>Aronson</surname><given-names>AE</given-names></string-name>, <string-name><surname>Brown</surname><given-names>JR</given-names></string-name>. <article-title>Differential diagnostic patterns of dysarthria</article-title>. <source xml:lang="en">J Speech Hear Res</source><year>1969</year>;<volume>12</volume>:<fpage>246</fpage>–<lpage>269</lpage>.<pub-id pub-id-type="pmid">5808852</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0007">
                <label>7</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0007"><string-name><surname>Darley</surname><given-names>FL</given-names></string-name>, <string-name><surname>Aronson</surname><given-names>AE</given-names></string-name>, <string-name><surname>Brown</surname><given-names>JR</given-names></string-name>. <article-title>Clusters of deviant speech dimensions in the dysarthrias</article-title>. <source xml:lang="en">J Speech Hear Res</source><year>1969</year>;<volume>12</volume>:<fpage>462</fpage>–<lpage>496</lpage>.<pub-id pub-id-type="pmid">5811846</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0008">
                <label>8</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0008"><string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <article-title>Vocal sound pressure level and self‐perception of speech and voice in men and women with idiopathic Parkinson disease</article-title>. <source xml:lang="en">Am J Speech Lang Pathol</source><year>1997</year>;<volume>6</volume>:<fpage>85</fpage>–<lpage>94</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0009">
                <label>9</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0009"><string-name><surname>Baumgartner</surname><given-names>CA</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <article-title>Voice quality changes following phonatory‐respiratory effort treatment (LSVT®) versus respiratory effort treatment for individuals with Parkinson disease</article-title>. <source xml:lang="en">J Voice</source><year>2001</year>;<volume>15</volume>:<fpage>105</fpage>–<lpage>114</lpage>.<pub-id pub-id-type="pmid">12269625</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0010">
                <label>10</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0010"><string-name><surname>Midi</surname><given-names>I</given-names></string-name>, <string-name><surname>Dogan</surname><given-names>M</given-names></string-name>, <string-name><surname>Koseoglu</surname><given-names>M</given-names></string-name>, <string-name><surname>Can</surname><given-names>G</given-names></string-name>, <string-name><surname>Sehitoglu</surname><given-names>MA</given-names></string-name>, <string-name><surname>Gunal</surname><given-names>DI</given-names></string-name>. <article-title>Voice abnormalities and their relation with motor dysfunction in Parkinson's disease</article-title>. <source xml:lang="en">Acta Neurol Scand</source><year>2008</year>;<volume>117</volume>:<fpage>26</fpage>–<lpage>34</lpage>.<pub-id pub-id-type="pmid">18031561</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0011">
                <label>11</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0011"><string-name><surname>Sewall</surname><given-names>GK</given-names></string-name>, <string-name><surname>Jiang</surname><given-names>J</given-names></string-name>, <string-name><surname>Ford</surname><given-names>CN</given-names></string-name>. <article-title>Clinical evaluation of Parkinson's‐related dysphonia</article-title>. <source xml:lang="en">Laryngoscope</source><year>2006</year>;<volume>116</volume>:<fpage>1740</fpage>–<lpage>1744</lpage>.<pub-id pub-id-type="pmid">17003722</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0012">
                <label>12</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0012"><string-name><surname>Plowman‐Prine</surname><given-names>EK</given-names></string-name>, <string-name><surname>Okun</surname><given-names>MS</given-names></string-name>, <string-name><surname>Sapienza</surname><given-names>CM</given-names></string-name>, et al. <article-title>Perceptual characteristics of Parkinsonian speech: a comparison of the pharmacological effects of levodopa across speech and non‐speech motor systems</article-title>. <source xml:lang="en">Neuro Rehabil</source><year>2009</year>;<volume>24</volume>:<fpage>131</fpage>–<lpage>144</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0013">
                <label>13</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0013"><string-name><surname>Lazarus</surname><given-names>JP</given-names></string-name>, <string-name><surname>Vibha</surname><given-names>D</given-names></string-name>, <string-name><surname>Handa</surname><given-names>KK</given-names></string-name>, et al. <article-title>A study of voice profiles and acoustic signs in patients with Parkinson's disease in North India</article-title>. <source xml:lang="en">J Clin Neurosci</source><year>2012</year>;<volume>19</volume>:<fpage>1125</fpage>–<lpage>1129</lpage>.<pub-id pub-id-type="pmid">22721893</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0014">
                <label>14</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0014"><string-name><surname>Ho</surname><given-names>AK</given-names></string-name>, <string-name><surname>Bradshaw</surname><given-names>JL</given-names></string-name>, <string-name><surname>Iansek</surname><given-names>R</given-names></string-name>, <string-name><surname>Alfredson</surname><given-names>R</given-names></string-name>. <article-title>Speech volume regulation in Parkinson's disease: effects of implicit cues and explicit instructions</article-title>. <source xml:lang="en">Neuropsychologia</source><year>1999</year>;<volume>37</volume>:<fpage>1453</fpage>–<lpage>1460</lpage>.<pub-id pub-id-type="pmid">10617265</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0015">
                <label>15</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0015"><string-name><surname>Logemann</surname><given-names>JA</given-names></string-name>, <string-name><surname>Fisher</surname><given-names>HB</given-names></string-name>. <article-title>Vocal tract control in Parkinson's disease: phonetic feature analysis of misarticulations</article-title>. <source xml:lang="en">J Speech Hear Disord</source><year>1981</year>;<volume>46</volume>:<fpage>348</fpage>–<lpage>352</lpage>.<pub-id pub-id-type="pmid">7300262</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0016">
                <label>16</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0016"><string-name><surname>Weismer</surname><given-names>G.</given-names></string-name><article-title>Acoustic descriptions of dysarthric speech: perceptual correlates and physiological inferences</article-title>. <source xml:lang="en">Semin Speech Lang</source><year>1984</year>;<volume>5</volume>:<fpage>293</fpage>–<lpage>314</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0017">
                <label>17</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0017"><string-name><surname>Forrest</surname><given-names>K</given-names></string-name>, <string-name><surname>Weismer</surname><given-names>G</given-names></string-name>, <string-name><surname>Turner</surname><given-names>GS</given-names></string-name>. <article-title>Kinematic, acoustic, and perceptual analyses of connected speech produced by Parkinsonian and normal geriatric adults</article-title>. <source xml:lang="en">J Acoust Soc Am</source><year>1989</year>;<volume>85</volume>:<fpage>2608</fpage>–<lpage>2622</lpage>.<pub-id pub-id-type="pmid">2745883</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0018">
                <label>18</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0018"><string-name><surname>Ackermann</surname><given-names>H</given-names></string-name>, <string-name><surname>Ziegler</surname><given-names>W</given-names></string-name>. <article-title>Articulatory deficits in Parkinsonian dysarthria: an acoustic analysis</article-title>. <source xml:lang="en">J Neurol Neurosurg Psychiatry</source><year>1991</year>;<volume>54</volume>:<fpage>1093</fpage>–<lpage>1098</lpage>.<pub-id pub-id-type="pmid">1783924</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0019">
                <label>19</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0019"><string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Spielman</surname><given-names>JL</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Story</surname><given-names>BH</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>. <article-title>Effects of intensive voice treatment (the Lee Silverman Voice Treatment [LSVT]) on vowel articulation in dysarthric individuals with idiopathic Parkinson disease: acoustic and perceptual findings</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2007</year>;<volume>50</volume>:<fpage>899</fpage>–<lpage>912</lpage>.<pub-id pub-id-type="pmid">17675595</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0020">
                <label>20</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0020"><string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Spielman</surname><given-names>JL</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>. <article-title>Formant centralization ratio: a proposal for a new acoustic measure of dysarthric speech</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2010</year>;<volume>53</volume>:<fpage>114</fpage>–<lpage>125</lpage>.<pub-id pub-id-type="pmid">19948755</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0021">
                <label>21</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0021"><string-name><surname>Skodda</surname><given-names>S</given-names></string-name>, <string-name><surname>Visser</surname><given-names>W</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>U</given-names></string-name>. <article-title>Vowel articulation in Parkinson's disease</article-title>. <source xml:lang="en">J Voice</source><year>2010</year>;<volume>25</volume>:<fpage>467</fpage>–<lpage>472</lpage>.<pub-id pub-id-type="pmid">20434876</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0022">
                <label>22</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0022"><string-name><surname>Rusz</surname><given-names>J</given-names></string-name>, <string-name><surname>Cmejla</surname><given-names>R</given-names></string-name>, <string-name><surname>Tykalova</surname><given-names>T</given-names></string-name>, et al. <article-title>Imprecise vowel articulation as a potential early marker of Parkinson's disease: effect of speaking task</article-title>. <source xml:lang="en">J Acoust Soc Am</source><year>2013</year>;<volume>134</volume>:<fpage>2171</fpage>–<lpage>2181</lpage>.<pub-id pub-id-type="pmid">23967947</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0023">
                <label>23</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0023"><string-name><surname>Tjaden</surname><given-names>K</given-names></string-name>, <string-name><surname>Lam</surname><given-names>J</given-names></string-name>, <string-name><surname>Wilding</surname><given-names>G</given-names></string-name>. <article-title>Vowel acoustics in Parkinson's disease and multiple sclerosis: comparison of clear, loud, and slow speaking conditions</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2013</year>;<volume>56</volume>:<fpage>1485</fpage>–<lpage>1502</lpage>.<pub-id pub-id-type="pmid">23838989</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0024">
                <label>24</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0024"><string-name><surname>Tjaden</surname><given-names>K</given-names></string-name>, <string-name><surname>Wilding</surname><given-names>GE</given-names></string-name>. <article-title>Rate and loudness manipulations in dysarthria: acoustic and perceptual findings</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2004</year>;<volume>47</volume>:<fpage>766</fpage>–<lpage>783</lpage>.<pub-id pub-id-type="pmid">15324285</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0025">
                <label>25</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0025"><string-name><surname>Skodda</surname><given-names>S</given-names></string-name>, <string-name><surname>Grönheit</surname><given-names>W</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>U</given-names></string-name>. <article-title>Impairment of vowel articulation as a possible marker of disease progression in Parkinson's disease</article-title>. <source xml:lang="en">PLoS One</source><year>2012</year>;<volume>7</volume>:<fpage>e32132</fpage>.<pub-id pub-id-type="pmid">22389682</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0026">
                <label>26</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0026"><string-name><surname>Hammen</surname><given-names>VL</given-names></string-name>, <string-name><surname>Yorkston</surname><given-names>KM</given-names></string-name>. <article-title>Speech and pause characteristics following speech rate reduction in hypokinetic dysarthria</article-title>. <source xml:lang="en">J Commun Disord</source><year>1996</year>;<volume>29</volume>:<fpage>429</fpage>–<lpage>445</lpage>.<pub-id pub-id-type="pmid">8956101</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0027">
                <label>27</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0027"><string-name><surname>Skodda</surname><given-names>S</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>U</given-names></string-name>. <article-title>Speech rate and rhythm in Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>2008</year>;<volume>23</volume>:<fpage>985</fpage>–<lpage>992</lpage>.<pub-id pub-id-type="pmid">18383114</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0028">
                <label>28</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0028"><string-name><surname>Blanchet</surname><given-names>PG</given-names></string-name>, <string-name><surname>Snyder</surname><given-names>GJ</given-names></string-name>. <article-title>Speech rate deficits in individuals with Parkinson's disease: a review of the literature</article-title>. <source xml:lang="en">J Med Speech Lang Pathol</source><year>2009</year>;<volume>17</volume>:<fpage>1</fpage>–<lpage>7</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0029">
                <label>29</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0029"><string-name><surname>Müller</surname><given-names>J</given-names></string-name>, <string-name><surname>Wenning</surname><given-names>GK</given-names></string-name>, <string-name><surname>Verny</surname><given-names>M</given-names></string-name>, et al. <article-title>Progression of dysarthria and dysphagia in postmortem‐confirmed Parkinsonian disorders</article-title>. <source xml:lang="en">Arch Neurol</source><year>2001</year>;<volume>58</volume>:<fpage>259</fpage>–<lpage>264</lpage>.<pub-id pub-id-type="pmid">11176964</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0030">
                <label>30</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0030"><string-name><surname>Stewart</surname><given-names>C</given-names></string-name>, <string-name><surname>Winfield</surname><given-names>L</given-names></string-name>, <string-name><surname>Hunt</surname><given-names>A</given-names></string-name>, et al. <article-title>Speech dysfunction in early Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>1995</year>;<volume>10</volume>:<fpage>562</fpage>–<lpage>565</lpage>.<pub-id pub-id-type="pmid">8552106</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0031">
                <label>31</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0031"><string-name><surname>Miller</surname><given-names>N</given-names></string-name>, <string-name><surname>Noble</surname><given-names>E</given-names></string-name>, <string-name><surname>Jones</surname><given-names>D</given-names></string-name>, <string-name><surname>Allcock</surname><given-names>L</given-names></string-name>, <string-name><surname>Burn</surname><given-names>DJ</given-names></string-name>. <article-title>How do I sound to me? Perceived changes in communication in Parkinson's disease</article-title>. <source xml:lang="en">Clin Rehabil</source><year>2008</year>;<volume>22</volume>:<fpage>14</fpage>–<lpage>22</lpage>.<pub-id pub-id-type="pmid">18089662</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0032">
                <label>32</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0032"><string-name><surname>Rusz</surname><given-names>J</given-names></string-name>, <string-name><surname>Cmejla</surname><given-names>R</given-names></string-name>, <string-name><surname>Ruzickova</surname><given-names>H</given-names></string-name>, <string-name><surname>Ruzicka</surname><given-names>E</given-names></string-name>. <article-title>Quantitative acoustic measurements for characterization of speech and voice disorders in early untreated Parkinson's disease</article-title>. <source xml:lang="en">J Acoust Soc Am</source><year>2011</year>;<volume>129</volume>:<fpage>350</fpage>–<lpage>367</lpage>.<pub-id pub-id-type="pmid">21303016</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0033">
                <label>33</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0033"><string-name><surname>Skodda</surname><given-names>S</given-names></string-name>, <string-name><surname>Grönheit</surname><given-names>W</given-names></string-name>, <string-name><surname>Mancinelli</surname><given-names>N</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>U</given-names></string-name>. <article-title>Progression of voice and speech impairment in the course of Parkinson's disease: a longitudinal study</article-title>. <source xml:lang="en">Parkinsons Dis</source><year>2013</year>;<volume>2013</volume>:<fpage>389195</fpage>.<pub-id pub-id-type="pmid">24386590</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0034">
                <label>34</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0034"><string-name><surname>King</surname><given-names>JB</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Lemke</surname><given-names>JH</given-names></string-name>, <string-name><surname>Horii</surname><given-names>Y</given-names></string-name>. <article-title>Parkinson's disease: longitudinal changes in acoustic parameters of phonation</article-title>. <source xml:lang="en">NCVS Status Prog Rep</source><year>1993</year>;<volume>4</volume>:<fpage>135</fpage>–<lpage>149</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0035">
                <label>35</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0035"><string-name><surname>Holmes</surname><given-names>RJ</given-names></string-name>, <string-name><surname>Oates</surname><given-names>JM</given-names></string-name>, <string-name><surname>Phyland</surname><given-names>DJ</given-names></string-name>, <string-name><surname>Hughes</surname><given-names>AJ</given-names></string-name>. <article-title>Voice characteristics in the progression of Parkinson's disease</article-title>. <source xml:lang="en">Int J Lang Commun Disord</source><year>2000</year>;<volume>35</volume>:<fpage>407</fpage>–<lpage>418</lpage>.<pub-id pub-id-type="pmid">10963022</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0036">
                <label>36</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0036"><string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Pawlas</surname><given-names>A</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, et al. <article-title>Speech and voice abnormalities in Parkinson disease: relation to severity of motor impairment, duration of disease, medication, depression, gender and age</article-title>. <source xml:lang="en">NCVS Status Prog Rep</source><year>1999</year>;<volume>14</volume>:<fpage>149</fpage>–<lpage>161</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0037">
                <label>37</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0037"><string-name><surname>Skodda</surname><given-names>S</given-names></string-name>, <string-name><surname>Rinsche</surname><given-names>H</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>U</given-names></string-name>. <article-title>Progression of dysprosody in Parkinson's disease over time—a longitudinal study</article-title>. <source xml:lang="en">Mov Disord</source><year>2009</year>;<volume>24</volume>:<fpage>716</fpage>–<lpage>722</lpage>.<pub-id pub-id-type="pmid">19117364</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0038">
                <label>38</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0038"><string-name><surname>Skodda</surname><given-names>S</given-names></string-name>, <string-name><surname>Flasskamp</surname><given-names>A</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>U</given-names></string-name>. <article-title>Instability of syllable repetition as a marker of disease progression in Parkinson's disease: a longitudinal study</article-title>. <source xml:lang="en">Mov Disord</source><year>2011</year>;<volume>26</volume>:<fpage>59</fpage>–<lpage>64</lpage>.<pub-id pub-id-type="pmid">20945431</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0039">
                <label>39</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0039"><string-name><surname>Miller</surname><given-names>N</given-names></string-name>, <string-name><surname>Noble</surname><given-names>E</given-names></string-name>, <string-name><surname>Jones</surname><given-names>D</given-names></string-name>, <string-name><surname>Burn</surname><given-names>D</given-names></string-name>. <article-title>Life with communication changes in Parkinson's disease</article-title>. <source xml:lang="en">Age Ageing</source><year>2006</year>;<volume>35</volume>:<fpage>235</fpage>–<lpage>239</lpage>.<pub-id pub-id-type="pmid">16540492</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0040">
                <label>40</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0040"><string-name><surname>Theodoros</surname><given-names>DG</given-names></string-name>. <chapter-title>Speech disorder in Parkinson disease</chapter-title> In: <person-group person-group-type="editor"><name><surname>Theodoros</surname><given-names>DG</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ramig</surname><given-names>LO</given-names></name></person-group>, eds. <source xml:lang="en">Communication and Swallowing in Parkinson Disease</source>. San Diego: Plural Publishing, <year>2011</year>:<fpage>51</fpage>–<lpage>88</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0041">
                <label>41</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0041"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <chapter-title>The role of phonation in speech intelligibility: a review and preliminary data from patients with Parkinson's disease</chapter-title> In: <person-group person-group-type="editor"><name><surname>Kent</surname><given-names>RD</given-names></name></person-group>, ed. <source xml:lang="en">Intelligibility in Speech Disorders: Theory, Measurement, and Management</source>. Amsterdam: John Benjamin, <year>1992</year>:<fpage>119</fpage>–<lpage>155</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0042">
                <label>42</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0042"><string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, <string-name><surname>Morrison</surname><given-names>CE</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>. <article-title>Current perspectives on the Lee Silverman Voice Treatment (LSVT) for individuals with idiopathic Parkinson disease</article-title>. <source xml:lang="en">Am J Speech Lang Pathol</source><year>2002</year>;<volume>11</volume>:<fpage>111</fpage>–<lpage>123</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0043">
                <label>43</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0043"><string-name><surname>Adams</surname><given-names>SG</given-names></string-name>, <string-name><surname>Haralabous</surname><given-names>O</given-names></string-name>, <string-name><surname>Dykstra</surname><given-names>A</given-names></string-name>, <string-name><surname>Abrams</surname><given-names>K</given-names></string-name>, <string-name><surname>Jog</surname><given-names>MS</given-names></string-name>. <article-title>Effects of multi‐talker background noise on the intensity of spoken sentences in Parkinson's disease</article-title>. <source xml:lang="en">Can Acoust</source><year>2005</year>;<volume>33</volume>:<fpage>94</fpage>–<lpage>95</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0044">
                <label>44</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0044"><string-name><surname>Neel</surname><given-names>AT</given-names></string-name>. <article-title>Effects of loud and amplified speech on sentence and word intelligibility in Parkinson disease</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2009</year>;<volume>52</volume>:<fpage>1021</fpage>–<lpage>1033</lpage>.<pub-id pub-id-type="pmid">18978211</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0045">
                <label>45</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0045"><string-name><surname>Hallett</surname><given-names>M</given-names></string-name>, <string-name><surname>Khoshbin</surname><given-names>S</given-names></string-name>. <article-title>A physiological mechanism of bradykinesia</article-title>. <source xml:lang="en">Brain</source><year>1980</year>;<volume>103</volume>:<fpage>301</fpage>–<lpage>314</lpage>.<pub-id pub-id-type="pmid">7397480</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0046">
                <label>46</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0046"><string-name><surname>Pfann</surname><given-names>KD</given-names></string-name>, <string-name><surname>Buchman</surname><given-names>AS</given-names></string-name>, <string-name><surname>Comella</surname><given-names>CL</given-names></string-name>, <string-name><surname>Corcos</surname><given-names>DM</given-names></string-name>. <article-title>Control of movement distance in Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>2001</year>;<volume>16</volume>:<fpage>1048</fpage>–<lpage>1065</lpage>.<pub-id pub-id-type="pmid">11748736</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0047">
                <label>47</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0047"><string-name><surname>Berardelli</surname><given-names>A</given-names></string-name>, <string-name><surname>Rothwell</surname><given-names>JC</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>PD</given-names></string-name>, <string-name><surname>Hallett</surname><given-names>M</given-names></string-name>. <article-title>Pathophysiology of bradykinesia in Parkinson's disease</article-title>. <source xml:lang="en">Brain</source><year>2001</year>;<volume>124</volume>:<fpage>2131</fpage>–<lpage>2146</lpage>.<pub-id pub-id-type="pmid">11673316</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0048">
                <label>48</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0048"><string-name><surname>Baker</surname><given-names>KK</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Luschei</surname><given-names>ES</given-names></string-name>, <string-name><surname>Smith</surname><given-names>ME</given-names></string-name>. <article-title>Thyroarytenoid muscle activity associated with hypophonia in Parkinson disease and aging</article-title>. <source xml:lang="en">Neurology</source><year>1998</year>;<volume>51</volume>:<fpage>1592</fpage>–<lpage>1598</lpage>.<pub-id pub-id-type="pmid">9855507</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0049">
                <label>49</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0049"><string-name><surname>Luschei</surname><given-names>ES</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Baker</surname><given-names>KL</given-names></string-name>, <string-name><surname>Smith</surname><given-names>ME</given-names></string-name>. <article-title>Discharge characteristics of laryngeal single motor units during phonation in young and older adults and in persons with Parkinson disease</article-title>. <source xml:lang="en">J Neurophysiol</source><year>1999</year>;<volume>81</volume>:<fpage>2131</fpage>–<lpage>2139</lpage>.<pub-id pub-id-type="pmid">10322054</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0050">
                <label>50</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0050"><string-name><surname>Sapir</surname><given-names>S.</given-names></string-name><article-title>Multiple factors are involved in the dysarthria associated with Parkinson's disease: a review with implications for clinical practice and research</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2014</year>;<volume>57</volume>:<fpage>1330</fpage>–<lpage>1343</lpage>.<pub-id pub-id-type="pmid">24686571</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0051">
                <label>51</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0051"><string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>. <article-title>Intensive voice treatment in Parkinson's disease: Lee Silverman Voice Treatment</article-title>. <source xml:lang="en">Expert Rev Neurother</source><year>2011</year>;<volume>11</volume>:<fpage>815</fpage>–<lpage>830</lpage>.<pub-id pub-id-type="pmid">21651330</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0052">
                <label>52</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0052"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>. <chapter-title>Speech and voice disorders in Parkinson's disease</chapter-title> In: <person-group person-group-type="editor"><name><surname>Olanow</surname><given-names>CW</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Stocchi</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Lang</surname><given-names>AE</given-names></name></person-group>, eds. <source xml:lang="en">Parkinson's Disease: Non‐Motor and Non‐Dopaminergic Features</source>. Oxford: Wiley–Blackwell, <year>2011</year>:<fpage>348</fpage>–<lpage>362</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0053">
                <label>53</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0053"><string-name><surname>Ho</surname><given-names>AK</given-names></string-name>, <string-name><surname>Bradshaw</surname><given-names>JL</given-names></string-name>, <string-name><surname>Iansek</surname><given-names>R</given-names></string-name>. <article-title>Volume perception in Parkinsonian speech</article-title>. <source xml:lang="en">Mov Disord</source><year>2000</year>;<volume>15</volume>:<fpage>1125</fpage>–<lpage>1131</lpage>.<pub-id pub-id-type="pmid">11104195</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0054">
                <label>54</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0054"><string-name><surname>Kwan</surname><given-names>LC</given-names></string-name>, <string-name><surname>Whitehill</surname><given-names>TL</given-names></string-name>. <article-title>Perception of speech by individuals with Parkinson's disease: a review</article-title>. <source xml:lang="en">Parkinsons Dis</source><year>2011</year>;<volume>2011</volume>:<fpage>389767</fpage>.<pub-id pub-id-type="pmid">21961077</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0055">
                <label>55</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0055"><string-name><surname>Mollaei</surname><given-names>F</given-names></string-name>, <string-name><surname>Shiller</surname><given-names>DM</given-names></string-name>, <string-name><surname>Gracco</surname><given-names>VL</given-names></string-name>. <article-title>Sensorimotor adaptation of speech in Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>2013</year>;<volume>28</volume>:<fpage>1668</fpage>–<lpage>1674</lpage>.<pub-id pub-id-type="pmid">23861349</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0056">
                <label>56</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0056"><string-name><surname>Arnold</surname><given-names>C</given-names></string-name>, <string-name><surname>Gehrig</surname><given-names>J</given-names></string-name>, <string-name><surname>Gispert</surname><given-names>S</given-names></string-name>, <string-name><surname>Seifried</surname><given-names>C</given-names></string-name>, <string-name><surname>Kell</surname><given-names>CA</given-names></string-name>. <article-title>Pathomechanisms and compensatory efforts related to Parkinsonian speech</article-title>. <source xml:lang="en">Neuroimage Clin</source><year>2014</year>;<volume>4</volume>:<fpage>82</fpage>–<lpage>97</lpage>.<pub-id pub-id-type="pmid">24319656</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0057">
                <label>57</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0057"><string-name><surname>Liu</surname><given-names>H</given-names></string-name>, <string-name><surname>Wang</surname><given-names>EQ</given-names></string-name>, <string-name><surname>Metman</surname><given-names>LV</given-names></string-name>, <string-name><surname>Larson</surname><given-names>CR</given-names></string-name>. <article-title>Vocal responses to perturbations in voice auditory feedback in individuals with Parkinson's disease</article-title>. <source xml:lang="en">PLoS One</source><year>2012</year>;<volume>7</volume>:<fpage>1</fpage>–<lpage>10</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0058">
                <label>58</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0058"><string-name><surname>Houde</surname><given-names>JF</given-names></string-name>, <string-name><surname>Nagarajan</surname><given-names>S</given-names></string-name>, <string-name><surname>Heinks</surname><given-names>T</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Marks</surname><given-names>WJ</given-names></string-name>. <article-title>The effect of voice therapy on feedback control in Parkinsonian speech</article-title>. <source xml:lang="en">Mov Disord</source><year>2004</year>;<volume>19</volume>:<fpage>S403</fpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0059">
                <label>59</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0059"><string-name><surname>Guehl</surname><given-names>D</given-names></string-name>, <string-name><surname>Burbaud</surname><given-names>P</given-names></string-name>, <string-name><surname>Lorenzi</surname><given-names>C</given-names></string-name>, et al. <article-title>Auditory temporal processing in Parkinson's disease</article-title>. <source xml:lang="en">Neuropsychologia</source><year>2008</year>;<volume>46</volume>:<fpage>2326</fpage>–<lpage>2335</lpage>.<pub-id pub-id-type="pmid">18439632</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0060">
                <label>60</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0060"><string-name><surname>Clark</surname><given-names>JP</given-names></string-name>, <string-name><surname>Adams</surname><given-names>SG</given-names></string-name>, <string-name><surname>Dykstra</surname><given-names>AD</given-names></string-name>, <string-name><surname>Moodie</surname><given-names>S</given-names></string-name>, <string-name><surname>Jog</surname><given-names>M</given-names></string-name>. <article-title>Loudness perception and speech intensity control in Parkinson's disease</article-title>. <source xml:lang="en">J Commun Disord</source><year>2014</year>;<volume>51</volume>:<fpage>1</fpage>–<lpage>12</lpage>.<pub-id pub-id-type="pmid">25194745</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0061">
                <label>61</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0061"><string-name><surname>Schulz</surname><given-names>GM</given-names></string-name>, <string-name><surname>Grant</surname><given-names>MK</given-names></string-name>. <article-title>Effects of speech therapy and pharmacologic and surgical treatments on voice and speech in Parkinson's disease: a review of the literature</article-title>. <source xml:lang="en">J Commun Disord</source><year>2000</year>;<volume>33</volume>:<fpage>59</fpage>–<lpage>88</lpage>.<pub-id pub-id-type="pmid">10665513</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0062">
                <label>62</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0062"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Fox</surname><given-names>C</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>. <chapter-title>Speech disorders in Parkinson's disease and the effects of pharmacological, surgical and speech treatment with emphasis on Lee Silverman voice treatment (LSVT®)</chapter-title> In: <person-group person-group-type="editor"><name><surname>Koller</surname><given-names>WC</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Melamed</surname><given-names>E</given-names></name></person-group>, eds. <source xml:lang="en">Handbook of Clinical Neurology Volume 83 (3rd series) Parkinson's Disease and Related Disorders, Part 1</source>. <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier B.V.</publisher-name>, <year>2007</year>:<fpage>385</fpage>–<lpage>399</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0063">
                <label>63</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0063"><string-name><surname>Pinto</surname><given-names>S</given-names></string-name>, <string-name><surname>Gentil</surname><given-names>M</given-names></string-name>, <string-name><surname>Krack</surname><given-names>P</given-names></string-name>, <string-name><surname>Sauleau</surname><given-names>P</given-names></string-name>, <string-name><surname>Fraix</surname><given-names>V</given-names></string-name>, <string-name><surname>Benabid</surname><given-names>AL</given-names></string-name>, <string-name><surname>Pollak</surname><given-names>P</given-names></string-name>. <article-title>Changes induced by levodopa and subthalamic nucleus stimulation on Parkinsonian speech</article-title>. <source xml:lang="en">Mov Disord</source><year>2005</year>;<volume>20</volume>:<fpage>1507</fpage>–<lpage>1515</lpage>.<pub-id pub-id-type="pmid">16037917</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0064">
                <label>64</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0064"><string-name><surname>Pinto</surname><given-names>S</given-names></string-name>, <string-name><surname>Ozsancak</surname><given-names>C</given-names></string-name>, <string-name><surname>Tripoliti</surname><given-names>E</given-names></string-name>, <string-name><surname>Thobois</surname><given-names>S</given-names></string-name>, <string-name><surname>Limousin‐Dowsey</surname><given-names>P</given-names></string-name>, <string-name><surname>Auzou</surname><given-names>P</given-names></string-name>. <article-title>Treatments for dysarthria in Parkinson's disease</article-title>. <source xml:lang="en">Lancet Neurol</source><year>2004</year>;<volume>3</volume>:<fpage>547</fpage>–<lpage>556</lpage>.<pub-id pub-id-type="pmid">15324723</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0065">
                <label>65</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0065"><string-name><surname>Trail</surname><given-names>M</given-names></string-name>, <string-name><surname>Fox</surname><given-names>C</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Howard</surname><given-names>J</given-names></string-name>, <string-name><surname>Lai</surname><given-names>EC</given-names></string-name>. <article-title>Speech treatment for Parkinson's disease</article-title>. <source xml:lang="en">NeuroRehabilitation</source><year>2005</year>;<volume>20</volume>:<fpage>205</fpage>–<lpage>221</lpage>.<pub-id pub-id-type="pmid">16340101</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0066">
                <label>66</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0066"><string-name><surname>Larson</surname><given-names>K</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Scherer</surname><given-names>RC</given-names></string-name>. <article-title>Acoustic and glottographic voice analysis during drug‐related fluctuation in Parkinson's disease</article-title>. <source xml:lang="en">J Med Speech Lang Pathol</source><year>1994</year>;<volume>2</volume>:<fpage>227</fpage>–<lpage>239</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0067">
                <label>67</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0067"><string-name><surname>D'Alatri</surname><given-names>L</given-names></string-name>, <string-name><surname>Paludetti</surname><given-names>G</given-names></string-name>, <string-name><surname>Contarino</surname><given-names>MF</given-names></string-name>, <string-name><surname>Galla</surname><given-names>S</given-names></string-name>, <string-name><surname>Marchese</surname><given-names>MR</given-names></string-name>, <string-name><surname>Bentivoglio</surname><given-names>AR</given-names></string-name>. <article-title>Effects of bilateral subthalamic nucleus stimulation and medication on Parkinsonian speech impairment</article-title>. <source xml:lang="en">J Voice</source><year>2008</year>;<volume>22</volume>:<fpage>365</fpage>–<lpage>372</lpage>.<pub-id pub-id-type="pmid">17368837</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0068">
                <label>68</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0068"><string-name><surname>Ho</surname><given-names>AK</given-names></string-name>, <string-name><surname>Bradshaw</surname><given-names>JL</given-names></string-name>, <string-name><surname>Iansek</surname><given-names>R</given-names></string-name>. <article-title>For better or worse: the effect of Levodopa on speech in Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>2008</year>;<volume>23</volume>:<fpage>574</fpage>–<lpage>580</lpage>.<pub-id pub-id-type="pmid">18163453</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0069">
                <label>69</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0069"><string-name><surname>Skodda</surname><given-names>S</given-names></string-name>, <string-name><surname>Visser</surname><given-names>W</given-names></string-name>, <string-name><surname>Schlegel</surname><given-names>U</given-names></string-name>. <article-title>Short‐ and long‐term dopaminergic effects on dysarthria in early Parkinson's disease</article-title>. <source xml:lang="en">J Neural Transm</source><year>2010</year>;<volume>117</volume>:<fpage>197</fpage>–<lpage>205</lpage>.<pub-id pub-id-type="pmid">20012657</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0070">
                <label>70</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0070"><string-name><surname>Skodda</surname><given-names>S.</given-names></string-name><article-title>Effect of deep brain stimulation on speech performance in Parkinson's disease</article-title>. <source xml:lang="en">Parkinsons Dis</source><year>2012</year>;<volume>2012</volume>:<fpage>850596</fpage>.<pub-id pub-id-type="pmid">23227426</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0071">
                <label>71</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0071"><string-name><surname>Deuschl</surname><given-names>G</given-names></string-name>, <string-name><surname>Paschen</surname><given-names>S</given-names></string-name>, <string-name><surname>Witt</surname><given-names>K</given-names></string-name>. <chapter-title>Clinical outcome of deep brain stimulation for Parkinson's disease</chapter-title> In: <person-group person-group-type="editor"><name><surname>Lozano</surname><given-names>AM</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Hallett</surname><given-names>M</given-names></name></person-group>, eds. <source xml:lang="en">Handbook of Clinical Neurology (volume 116, 3rd series) Brain Stimulation</source>. Amsterdam: Elsevier B.V., <year>2013</year>:<fpage>107</fpage>–<lpage>128</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0072">
                <label>72</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0072"><string-name><surname>Tripoliti</surname><given-names>E</given-names></string-name>, <string-name><surname>Zrinzo</surname><given-names>L</given-names></string-name>, <string-name><surname>Martinez‐Torres</surname><given-names>I</given-names></string-name>, et al. <article-title>Effects of contact location and voltage amplitude on speech and movement in bilateral subthalamic nucleus deep brain stimulation</article-title>. <source xml:lang="en">Mov Disord</source><year>2008</year>;<volume>23</volume>:<fpage>2377</fpage>–<lpage>2383</lpage>.<pub-id pub-id-type="pmid">18785648</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0073">
                <label>73</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0073"><string-name><surname>Goberman</surname><given-names>AM</given-names></string-name>, <string-name><surname>Coelho</surname><given-names>C</given-names></string-name>. <article-title>Acoustic analysis of Parkinsonian speech I: speech characteristics and L‐Dopa therapy</article-title>. <source xml:lang="en">NeuroRehabilitation</source><year>2002</year>;<volume>17</volume>:<fpage>237</fpage>–<lpage>246</lpage>.<pub-id pub-id-type="pmid">12237505</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0074">
                <label>74</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0074"><string-name><surname>Allan</surname><given-names>CM</given-names></string-name>. <article-title>Treatment of non‐fluent speech resulting from neurological disease—treatment of dysarthria</article-title>. <source xml:lang="en">Br J Disord Commun</source><year>1970</year>;<volume>5</volume>: <fpage>3</fpage>–<lpage>5</lpage>.<pub-id pub-id-type="pmid">5504026</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0075">
                <label>75</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0075"><string-name><surname>Aronson</surname><given-names>AE</given-names></string-name>. <article-title>Organic voice disorders: neurologic disease</article-title>. <source xml:lang="en">Clin Voice Disord</source><year>1985</year>;<volume>2</volume>:<fpage>76</fpage>–<lpage>125</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0076">
                <label>76</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0076"><string-name><surname>Greene</surname><given-names>HCL</given-names></string-name>. <source xml:lang="en">The Voice and Its Disorders</source>. <publisher-loc>London</publisher-loc>: <publisher-name>Pitman Medical</publisher-name>; <year>1980</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0077">
                <label>77</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0077"><string-name><surname>Sarno</surname><given-names>MT</given-names></string-name>. <article-title>Speech impairment in Parkinson's disease</article-title>. <source xml:lang="en">Arch Phys Med Rehabil</source><year>1968</year>;<volume>49</volume>:<fpage>269</fpage>–<lpage>275</lpage>.<pub-id pub-id-type="pmid">5651680</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0078">
                <label>78</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0078"><string-name><surname>Weiner</surname><given-names>WJ</given-names></string-name>, <string-name><surname>Singer</surname><given-names>C</given-names></string-name>. <article-title>Parkinson's disease and nonpharmacologic treatment programs</article-title>. <source xml:lang="en">J Am Geriatr Soc</source><year>1989</year>;<volume>37</volume>:<fpage>359</fpage>–<lpage>363</lpage>.<pub-id pub-id-type="pmid">2646351</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0079">
                <label>79</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0079"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Bonitati</surname><given-names>CM</given-names></string-name>, <string-name><surname>Lemke</surname><given-names>JH</given-names></string-name>, <string-name><surname>Horii</surname><given-names>Y</given-names></string-name>. <article-title>Voice treatment for patients with Parkinson disease: development of an approach and preliminary efficacy data</article-title>. <source xml:lang="en">J Med Speech Lang Pathol</source><year>1994</year>;<volume>2</volume>:<fpage>191</fpage>–<lpage>209</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0080">
                <label>80</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0080"><string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>. <chapter-title>Assessment and treatment of the speech disorder in Parkinson disease</chapter-title> In: <person-group person-group-type="editor"><name><surname>Theodoros</surname><given-names>DG</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ramig</surname><given-names>LO</given-names></name></person-group>, eds. <source xml:lang="en">Communication and Swallowing in Parkinson Disease</source>. San Diego: Plural Publishing, <year>2011</year>:<fpage>89</fpage>–<lpage>122</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0081">
                <label>81</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0081"><string-name><surname>Kleim</surname><given-names>JA</given-names></string-name>, <string-name><surname>Jones</surname><given-names>TA</given-names></string-name>, <string-name><surname>Schallert</surname><given-names>T</given-names></string-name>. <article-title>Motor enrichment and the induction of plasticity before or after brain injury</article-title>. <source xml:lang="en">Neurochem Res</source><year>2003</year>;<volume>28</volume>:<fpage>1757</fpage>–<lpage>1769</lpage>.<pub-id pub-id-type="pmid">14584829</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0082">
                <label>82</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0082"><string-name><surname>Kleim</surname><given-names>JA</given-names></string-name>, <string-name><surname>Jones</surname><given-names>TA</given-names></string-name>. <article-title>Principles of experience‐dependent neural plasticity: implications for rehabilitation after brain damage</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2008</year>;<volume>51</volume>:<fpage>S225</fpage>–<lpage>S239</lpage>.<pub-id pub-id-type="pmid">18230848</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0083">
                <label>83</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0083"><string-name><surname>Baker</surname><given-names>E.</given-names></string-name><article-title>Optimal intervention intensity in speech‐language pathology: discoveries, challenges, and unchartered territories</article-title>. <source xml:lang="en">Int J Speech Lang Pathol</source><year>2012</year>;<volume>14</volume>:<fpage>478</fpage>–<lpage>485</lpage>.<pub-id pub-id-type="pmid">22974107</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0084">
                <label>84</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0084"><string-name><surname>Ahlskog</surname><given-names>JE</given-names></string-name>. <article-title>Does vigorous exercise have a neuroprotective effect in Parkinson disease?</article-title><source xml:lang="en">Neurology</source><year>2011</year>;<volume>77</volume>:<fpage>288</fpage>–<lpage>294</lpage>.<pub-id pub-id-type="pmid">21768599</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0085">
                <label>85</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0085"><string-name><surname>Frazzitta</surname><given-names>G</given-names></string-name>, <string-name><surname>Maestri</surname><given-names>R</given-names></string-name>, <string-name><surname>Bertotti</surname><given-names>G</given-names></string-name>, et al. <article-title>Intensive rehabilitation treatment in early Parkinson's disease: a randomized pilot study with a 2‐year follow‐up</article-title>. <source xml:lang="en">Neurorehabil Neural Repair</source><year>2015</year>;<volume>29</volume>:<fpage>123</fpage>–<lpage>131</lpage>.<pub-id pub-id-type="pmid">25038064</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0086">
                <label>86</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0086"><string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Ciucci</surname><given-names>MR</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>McFarland</surname><given-names>DH</given-names></string-name>, <string-name><surname>Farley</surname><given-names>BG</given-names></string-name>. <article-title>The science and practice of LSVT/LOUD: neural plasticity‐principled approach to treating individuals with Parkinson disease and other neurological disorders</article-title>. <source xml:lang="en">Semin Speech Lang</source><year>2006</year>;<volume>27</volume>:<fpage>283</fpage>–<lpage>299</lpage>.<pub-id pub-id-type="pmid">17117354</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0087">
                <label>87</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0087"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Countryman</surname><given-names>S</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>LL</given-names></string-name>, <string-name><surname>Horii</surname><given-names>Y</given-names></string-name>. <article-title>Comparison of two forms of intensive speech treatment for Parkinson disease</article-title>. <source xml:lang="en">J Speech Hear Res</source><year>1995</year>;<volume>38</volume>:<fpage>1232</fpage>–<lpage>1251</lpage>.<pub-id pub-id-type="pmid">8747817</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0088">
                <label>88</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0088"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Countryman</surname><given-names>S</given-names></string-name>, <string-name><surname>O'Brien</surname><given-names>C</given-names></string-name>, <string-name><surname>Hoehn</surname><given-names>M</given-names></string-name>, <string-name><surname>Thompson</surname><given-names>LL</given-names></string-name>. <article-title>Intensive speech treatment for patients with Parkinson's disease: short‐ and long‐term comparison of two techniques</article-title>. <source xml:lang="en">Neurology</source><year>1996</year>;<volume>47</volume>:<fpage>1496</fpage>–<lpage>1504</lpage>.<pub-id pub-id-type="pmid">8960734</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0089">
                <label>89</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0089"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Countryman</surname><given-names>S</given-names></string-name>, et al. <article-title>Intensive voice treatment (LSVT®) for individuals with Parkinson's disease: a two‐year follow‐up</article-title>. <source xml:lang="en">J Neurol Neurosurg Psychiatry</source><year>2001</year>;<volume>71</volume>:<fpage>493</fpage>–<lpage>498</lpage>.<pub-id pub-id-type="pmid">11561033</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0090">
                <label>90</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0090"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, <string-name><surname>Countryman</surname><given-names>S</given-names></string-name>. <article-title>Changes in vocal loudness following intensive voice treatment (LSVT®) in individuals with Parkinson's disease: a comparison with untreated patients and normal age‐matched controls</article-title>. <source xml:lang="en">Mov Disord</source><year>2001</year>;<volume>16</volume>:<fpage>79</fpage>–<lpage>83</lpage>.<pub-id pub-id-type="pmid">11215597</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0091">
                <label>91</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0091"><string-name><surname>Dromey</surname><given-names>C</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Johnson</surname><given-names>AB</given-names></string-name>. <article-title>Phonatory and articulatory changes associated with increased vocal intensity in Parkinson disease: a case study</article-title>. <source xml:lang="en">J Speech Hear Res</source><year>1995</year>;<volume>38</volume>:<fpage>751</fpage>–<lpage>764</lpage>.<pub-id pub-id-type="pmid">7474969</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0092">
                <label>92</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0092"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Dromey</surname><given-names>C</given-names></string-name>. <article-title>Aerodynamic mechanisms underlying treatment‐related changes in vocal intensity in patients with Parkinson disease</article-title>. <source xml:lang="en">J Speech Hear Res</source><year>1996</year>;<volume>39</volume>:<fpage>798</fpage>–<lpage>807</lpage>.<pub-id pub-id-type="pmid">8844559</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0093">
                <label>93</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0093"><string-name><surname>El Sharkawi</surname><given-names>A</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Logemann</surname><given-names>JA</given-names></string-name>, et al. <article-title>Swallowing and voice effects of Lee Silverman Voice Treatment (LSVT®): a pilot study</article-title>. <source xml:lang="en">J Neurol Neurosurg Psychiatry</source><year>2002</year>;<volume>72</volume>:<fpage>31</fpage>–<lpage>36</lpage>.<pub-id pub-id-type="pmid">11784821</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0094">
                <label>94</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0094"><string-name><surname>Spielman</surname><given-names>JL</given-names></string-name>, <string-name><surname>Borod</surname><given-names>JC</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <article-title>The effects of intensive voice treatment on facial expressiveness in Parkinson disease: preliminary data</article-title>. <source xml:lang="en">Cogn Behav Neurol</source><year>2003</year>;<volume>16</volume>:<fpage>177</fpage>–<lpage>188</lpage>.<pub-id pub-id-type="pmid">14501539</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0095">
                <label>95</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0095"><string-name><surname>McClean</surname><given-names>MD</given-names></string-name>, <string-name><surname>Tasko</surname><given-names>SM</given-names></string-name>. <article-title>Association of orofacial with laryngeal and respiratory motor output during speech</article-title>. <source xml:lang="en">Exp Brain Res</source><year>2002</year>;<volume>146</volume>:<fpage>481</fpage>–<lpage>489</lpage>.<pub-id pub-id-type="pmid">12355277</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0096">
                <label>96</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0096"><string-name><surname>McFarland</surname><given-names>DH</given-names></string-name>, <string-name><surname>Tremblay</surname><given-names>P</given-names></string-name>. <article-title>Clinical implications of cross‐system interactions</article-title>. <source xml:lang="en">Semin Speech Lang</source><year>2006</year>;<volume>27</volume>:<fpage>300</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">17117355</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0097">
                <label>97</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0097"><string-name><surname>Cookman</surname><given-names>S</given-names></string-name>, <string-name><surname>Verdolini</surname><given-names>K</given-names></string-name>. <article-title>Interrelation of mandibular laryngeal functions</article-title>. <source xml:lang="en">J Voice</source><year>1999</year>;<volume>13</volume>:<fpage>11</fpage>–<lpage>24</lpage>.<pub-id pub-id-type="pmid">10223671</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0098">
                <label>98</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0098"><string-name><surname>Higgins</surname><given-names>MB</given-names></string-name>, <string-name><surname>Netsell</surname><given-names>R</given-names></string-name>, <string-name><surname>Schulte</surname><given-names>L</given-names></string-name>. <article-title>Vowel‐related differences in laryngeal articulatory and phonatory function</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>1998</year>;<volume>41</volume>:<fpage>712</fpage>–<lpage>724</lpage>.<pub-id pub-id-type="pmid">9712121</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0099">
                <label>99</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0099"><string-name><surname>Larson</surname><given-names>KK</given-names></string-name>, <string-name><surname>Sapir</surname><given-names>S</given-names></string-name>. <article-title>Orolaryngeal reflex responses to changes in affective state</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>1995</year>;<volume>38</volume>:<fpage>990</fpage>–<lpage>1000</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0100">
                <label>100</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0100"><string-name><surname>Sapir</surname><given-names>S.</given-names></string-name><article-title>The intrinsic path of vowels: theoretical, physiological, and clinical considerations</article-title>. <source xml:lang="en">J Voice</source><year>1989</year>;<volume>3</volume>:<fpage>44</fpage>–<lpage>51</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0101">
                <label>101</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0101"><string-name><surname>Duffy</surname><given-names>JF</given-names></string-name>. <chapter-title>Hypokinetic dysarthria</chapter-title> In: <person-group person-group-type="editor"><name><surname>Duffy</surname><given-names>JR</given-names></name></person-group>, ed. <source xml:lang="en">Motor Speech Disorders: Substrates, Differential Diagnosis, and Management</source>. St. Louis: Mosby, <year>2005</year>:<fpage>187</fpage>–<lpage>215</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0102">
                <label>102</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0102"><string-name><surname>Rosenbek</surname><given-names>JC</given-names></string-name>, <string-name><surname>LaPointe</surname><given-names>LL</given-names></string-name>. <chapter-title>The dysarthrias: description, diagnosis, and treatment</chapter-title> In: <person-group person-group-type="editor"><name><surname>Johns</surname><given-names>D</given-names></name></person-group>, ed. <source xml:lang="en">Clinical Management of Neurogenic Communicative Disorders</source>. Boston: Little, Brown, and Co., <year>1985</year>:<fpage>97</fpage>–<lpage>152</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0103">
                <label>103</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0103"><string-name><surname>Yorkston</surname><given-names>KM</given-names></string-name>, <string-name><surname>Beukelman</surname><given-names>DR</given-names></string-name>, <string-name><surname>Bell</surname><given-names>KR</given-names></string-name>. <source xml:lang="en">Clinical Management of Dysarthric Speakers</source>. <publisher-loc>Boston, MA</publisher-loc>: <publisher-name>College Hill Press</publisher-name>; <year>1988</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0104">
                <label>104</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0104"><string-name><surname>Dromey</surname><given-names>C.</given-names></string-name><article-title>Articulatory kinematics in patients with Parkinson disease using different speech treatment approaches</article-title>. <source xml:lang="en">J Med Speech Lang Pathol</source><year>2000</year>;<volume>8</volume>:<fpage>155</fpage>–<lpage>161</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0105">
                <label>105</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0105"><string-name><surname>Goberman</surname><given-names>AM</given-names></string-name>, <string-name><surname>Elmer</surname><given-names>LW</given-names></string-name>. <article-title>Acoustic analysis of clear versus conversational speech in individuals with Parkinson disease</article-title>. <source xml:lang="en">J Commun Disord</source><year>2005</year>;<volume>38</volume>:<fpage>215</fpage>–<lpage>230</lpage>.<pub-id pub-id-type="pmid">15748725</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0106">
                <label>106</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0106"><string-name><surname>Schwartz</surname><given-names>CE</given-names></string-name>, <string-name><surname>Chesney</surname><given-names>MA</given-names></string-name>, <string-name><surname>Irvine</surname><given-names>MJ</given-names></string-name>, <string-name><surname>Keefe</surname><given-names>FJ</given-names></string-name>. <article-title>The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials</article-title>. <source xml:lang="en">Psychosom Med</source><year>1997</year>;<volume>59</volume>:<fpage>362</fpage>–<lpage>371</lpage>.<pub-id pub-id-type="pmid">9251155</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0107">
                <label>107</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0107"><string-name><surname>Rains</surname><given-names>JC</given-names></string-name>, <string-name><surname>Penzien</surname><given-names>DB</given-names></string-name>. <article-title>Behavioral research and the double‐blind placebo‐controlled methodology: challenges in applying biomedical standard to behavioral headache research</article-title>. <source xml:lang="en">Headache</source><year>2005</year>;<volume>45</volume>:<fpage>479</fpage>–<lpage>486</lpage>.<pub-id pub-id-type="pmid">15953264</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0108">
                <label>108</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0108"><string-name><surname>Atkinson‐Clement</surname><given-names>C</given-names></string-name>, <string-name><surname>Sadat</surname><given-names>J</given-names></string-name>, <string-name><surname>Pinto</surname><given-names>S</given-names></string-name>. <article-title>Behavioral treatments for speech in Parkinson's disease: meta‐analyses and review of the literature</article-title>. <source xml:lang="en">Neurodegener Dis Manag</source><year>2015</year>;<volume>5</volume>:<fpage>233</fpage>–<lpage>248</lpage>.<pub-id pub-id-type="pmid">26107322</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0109">
                <label>109</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0109"><string-name><surname>Herd</surname><given-names>CP</given-names></string-name>, <string-name><surname>Tomlinson</surname><given-names>CL</given-names></string-name>, <string-name><surname>Deane</surname><given-names>KH</given-names></string-name>, et al. <article-title>Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease</article-title>. <source xml:lang="en">Cochrane Database Syst Rev</source><year>2012</year>;(<volume>8</volume>):<fpage>CD002812</fpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0110">
                <label>110</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0110"><string-name><surname>Boutron</surname><given-names>I</given-names></string-name>, <string-name><surname>Moher</surname><given-names>D</given-names></string-name>, <string-name><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name><surname>Schulz</surname><given-names>KF</given-names></string-name>, <string-name><surname>Ravaud</surname><given-names>P</given-names></string-name>. <article-title>Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration</article-title>. <source xml:lang="en">Ann Intern Med</source><year>2008</year>;<volume>148</volume>:<fpage>295</fpage>–<lpage>309</lpage>.<pub-id pub-id-type="pmid">18283207</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0111">
                <label>111</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0111"><string-name><surname>Boutron</surname><given-names>I</given-names></string-name>, <string-name><surname>Altman</surname><given-names>DG</given-names></string-name>, <string-name><surname>Moher</surname><given-names>D</given-names></string-name>, <string-name><surname>Schulz</surname><given-names>KF</given-names></string-name>, <string-name><surname>Ravaud</surname><given-names>P</given-names></string-name>. <article-title>CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trials abstracts</article-title>. <source xml:lang="en">Ann Intern Med</source><year>2017</year>;<volume>167</volume>:<fpage>40</fpage>–<lpage>47</lpage>.<pub-id pub-id-type="pmid">28630973</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0112">
                <label>112</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0112"><string-name><surname>Scanlon</surname><given-names>PD</given-names></string-name>, <string-name><surname>Connett</surname><given-names>JE</given-names></string-name>, <string-name><surname>Waller</surname><given-names>LA</given-names></string-name>, et al. <article-title>Smoking cessation and lung function in mild‐to‐moderate chronic obstructive pulmonary disease: the lung health study</article-title>. <source xml:lang="en">Am J Respir Crit Care Med</source><year>2000</year>;<volume>161</volume>:<fpage>381</fpage>–<lpage>390</lpage>.<pub-id pub-id-type="pmid">10673175</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0113">
                <label>113</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0113"><string-name><surname>Hoehn</surname><given-names>MM</given-names></string-name>, <string-name><surname>Yahr</surname><given-names>MD</given-names></string-name>. <article-title>Parkinsonism: onset, progression, and mortality</article-title>. <source xml:lang="en">Neurology</source><year>1967</year>;<volume>17</volume>:<fpage>427</fpage>–<lpage>442</lpage>.<pub-id pub-id-type="pmid">6067254</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0114">
                <label>114</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0114"><string-name><surname>Folstein</surname><given-names>MF</given-names></string-name>, <string-name><surname>Folstein</surname><given-names>SE</given-names></string-name>, <string-name><surname>McHugh</surname><given-names>PR</given-names></string-name>. <article-title>Mini‐mental state: a practical method for grading the cognitive state of patients for the clinician</article-title>. <source xml:lang="en">J Psychiatr Res</source><year>1975</year>;<volume>12</volume>:<fpage>189</fpage>–<lpage>198</lpage>.<pub-id pub-id-type="pmid">1202204</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0115">
                <label>115</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0115"><string-name><surname>Beck</surname><given-names>AT</given-names></string-name>, <string-name><surname>Steer</surname><given-names>RA</given-names></string-name>, <string-name><surname>Brown</surname><given-names>GK</given-names></string-name>. <source xml:lang="en">Manual for the Beck Depression Inventory‐II</source>. <publisher-loc>San Antonio, TX</publisher-loc>: <publisher-name>The Psychological Corporation</publisher-name>, <year>1996</year>:<fpage>38</fpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0116">
                <label>116</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0116"><string-name><surname>Blitzer</surname><given-names>A</given-names></string-name>, <string-name><surname>Brin</surname><given-names>MF</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <source xml:lang="en">Neurologic Disorders of the Larynx</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Thieme</publisher-name>; <year>2011</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0117">
                <label>117</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0117"><string-name><surname>Logemann</surname><given-names>JA</given-names></string-name>. <source xml:lang="en">The Evaluation and Treatment of Swallowing Disorders</source>, <edition>2nd</edition> ed. <publisher-loc>Austin, TX</publisher-loc>: <publisher-name>Pro‐Ed</publisher-name>; <year>1998</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0118">
                <label>118</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0118"><string-name><surname>Whelan</surname><given-names>BM</given-names></string-name>. <chapter-title>Assessment and treatment of cognitive‐linguistic disorder in Parkinson disease</chapter-title> In: <person-group person-group-type="editor"><name><surname>Theodoros</surname><given-names>DG</given-names></name></person-group>, <person-group person-group-type="editor"><name><surname>Ramig</surname><given-names>LO</given-names></name></person-group>, eds. <source xml:lang="en">Communication and Swallowing in Parkinson Disease</source>. San Diego: Plural Publishing; <year>2011</year>:<fpage>179</fpage>–<lpage>198</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0119">
                <label>119</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0119"><string-name><surname>Spielman</surname><given-names>J</given-names></string-name>, <string-name><surname>Halpern</surname><given-names>A</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>L</given-names></string-name>. Changes in speech production following intensive voice vs. intensive articulation therapy in Parkinson disease: a preliminary study. Poster session presented at: The 14th Biennial Conference on Motor Speech; <year>2008</year> March 6–9; Monterey, CA.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0120">
                <label>120</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0120"><string-name><surname>Halpern</surname><given-names>A</given-names></string-name>, <string-name><surname>Spielman</surname><given-names>J</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>L</given-names></string-name>, <string-name><surname>Cable</surname><given-names>J</given-names></string-name>, <string-name><surname>Panzer</surname><given-names>I</given-names></string-name>, <string-name><surname>Sharpley</surname><given-names>A</given-names></string-name>. The effects of loudness and noise on speech intelligibility in Parkinson disease. Poster session presented at: The 11th International Congress of Parkinson's Disease and Movement Disorders; <year>2007</year> June 3–7; Istanbul, Turkey.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0121">
                <label>121</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0121"><string-name><surname>Halpern</surname><given-names>A</given-names></string-name>, <string-name><surname>Spielman</surname><given-names>J</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>L</given-names></string-name>, <string-name><surname>Panzer</surname><given-names>I</given-names></string-name>, <string-name><surname>Sharpley</surname><given-names>A</given-names></string-name>, <string-name><surname>Gustafson</surname><given-names>H</given-names></string-name>. Speech intelligibility measured in noise: the effects of loudness vs. articulation treatment in Parkinson disease. Poster session presented at: The Annual Conference of the American Speech‐Language Hearing Association; <year>2008</year> November 20–22; Chicago, IL.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0122">
                <label>122</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0122"><string-name><surname>Robey</surname><given-names>RR</given-names></string-name>, <string-name><surname>Schultz</surname><given-names>MC</given-names></string-name>. <article-title>A model for conducting clinical‐outcome research: an adaptation of the standard protocol for use in aphasiology</article-title>. <source xml:lang="en">Aphasiology</source><year>1998</year>;<volume>12</volume>:<fpage>787</fpage>–<lpage>810</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0123">
                <label>123</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0123"><string-name><surname>Robey</surname><given-names>RR</given-names></string-name>. <article-title>A five‐phase model for clinical‐outcome research</article-title>. <source xml:lang="en">J Commun Disord</source><year>2004</year>;<volume>37</volume>:<fpage>401</fpage>–<lpage>411</lpage>.<pub-id pub-id-type="pmid">15231420</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0124">
                <label>124</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0124"><string-name><surname>Djulbegovic</surname><given-names>B</given-names></string-name>, <string-name><surname>Cantor</surname><given-names>A</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>M</given-names></string-name>. <article-title>The importance of the preservation of the ethical principle of equipoise in the design of clinical trials: relative impact of the methodological quality domains on the treatment effect in randomized controlled trials</article-title>. <source xml:lang="en">Account Res</source><year>2003</year>;<volume>10</volume>:<fpage>301</fpage>–<lpage>315</lpage>.<pub-id pub-id-type="pmid">14989285</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0125">
                <label>125</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0125"><string-name><surname>Goetz</surname><given-names>CG</given-names></string-name>, <string-name><surname>Janko</surname><given-names>K</given-names></string-name>, <string-name><surname>Blasucci</surname><given-names>L</given-names></string-name>, <string-name><surname>Jaglin</surname><given-names>JA</given-names></string-name>. <article-title>Impact of placebo assignment in clinical trials of Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>2003</year>;<volume>18</volume>:<fpage>1146</fpage>–<lpage>1149</lpage>.<pub-id pub-id-type="pmid">14534918</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0126">
                <label>126</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0126"><string-name><surname>Ball</surname><given-names>LJ</given-names></string-name>, <string-name><surname>Beukelman</surname><given-names>DR</given-names></string-name>, <string-name><surname>Pattee</surname><given-names>GL</given-names></string-name>. <article-title>Communication effectiveness of individuals with amyotrophic lateral sclerosis</article-title>. <source xml:lang="en">J Commun Disord</source><year>2004</year>;<volume>37</volume>:<fpage>197</fpage>–<lpage>215</lpage>.<pub-id pub-id-type="pmid">15063143</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0127">
                <label>127</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0127"><string-name><surname>Spielman</surname><given-names>J</given-names></string-name>, <string-name><surname>Gilley</surname><given-names>P</given-names></string-name>, <string-name><surname>Halpern</surname><given-names>A</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. Relationship of Communicative Effectiveness to Voice Handicap, Acoustics, and Behavioral Characteristics in People with Parkinson Disease. Poster session presented at: The 15th Biennial Conference on Motor Speech; <year>2010</year> March 7–10; Savannah, GA.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0128">
                <label>128</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0128"><string-name><surname>Dykstra</surname><given-names>A</given-names></string-name>, <string-name><surname>Adams</surname><given-names>S</given-names></string-name>, <string-name><surname>Jog</surname><given-names>M</given-names></string-name>. The effect of hypophonia on communication effectiveness in Parkinson's disease. Poster session presented at: The 14th Biennial Conference on Motor Speech; <year>2008</year> March 6–9; Monterey, CA.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0129">
                <label>129</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0129"><string-name><surname>Fairbanks</surname><given-names>G.</given-names></string-name><source xml:lang="en">Voice and Articulation Drillbook</source>. <publisher-loc>New York, NY</publisher-loc>: <publisher-name>Harder and Brothers</publisher-name>; <year>1960</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0130">
                <label>130</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0130"><string-name><surname>Crystal</surname><given-names>TH</given-names></string-name>, <string-name><surname>House</surname><given-names>AS</given-names></string-name>. <article-title>Segmental durations in connected speech signals: preliminary results</article-title>. <source xml:lang="en">J Acoust Soc Am</source><year>1982</year>;<volume>72</volume>:<fpage>705</fpage>–<lpage>716</lpage>.<pub-id pub-id-type="pmid">7130529</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0131">
                <label>131</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0131"><string-name><surname>Goodglass</surname><given-names>H</given-names></string-name>, <string-name><surname>Kaplan</surname><given-names>E</given-names></string-name>. <source xml:lang="en">The Assessment of Aphasia and Related Disorders</source>, <edition>2nd</edition> ed. <publisher-loc>Philadelphia, PA</publisher-loc>: <publisher-name>Lea &amp; Febiger</publisher-name>; <year>1983</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0132">
                <label>132</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0132"><string-name><surname>Borod</surname><given-names>JC</given-names></string-name>, <string-name><surname>Welkowitz</surname><given-names>J</given-names></string-name>, <string-name><surname>Obler</surname><given-names>LK</given-names></string-name>. The New York Emotion Battery. Unpublished materials, Mount Sinai Medical Center, Department of Neurology, New York, NY, <year>1992</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0133">
                <label>133</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0133"><string-name><surname>Švec</surname><given-names>JG</given-names></string-name>, <string-name><surname>Popolo</surname><given-names>PS</given-names></string-name>, <string-name><surname>Titze</surname><given-names>IR</given-names></string-name>. <article-title>Measurement of vocal doses in speech: experimental procedure and signal processing</article-title>. <source xml:lang="en">Logoped Phoniatr Vocol</source><year>2003</year>;<volume>28</volume>:<fpage>181</fpage>–<lpage>192</lpage>.<pub-id pub-id-type="pmid">14686546</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0134">
                <label>134</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0134"><string-name><surname>de Riesthal</surname><given-names>M</given-names></string-name>, <string-name><surname>Ross</surname><given-names>KB</given-names></string-name>. <article-title>Patient reported outcome measures in neurologic communication disorders: an update</article-title>. <source xml:lang="en">Perspect Neurophysiol Neurogen Speech Lang Disord</source><year>2015</year>;<volume>25</volume>:<fpage>114</fpage>–<lpage>120</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0135">
                <label>135</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0135"><string-name><surname>Cohen</surname><given-names>J.</given-names></string-name><article-title>Statistical power analysis</article-title>. <source xml:lang="en">Curr Dir Psychol Sci</source><year>1992</year>;<volume>1</volume>:<fpage>98</fpage>–<lpage>101</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0136">
                <label>136</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0136"><string-name><surname>Tomlinson</surname><given-names>CL</given-names></string-name>, <string-name><surname>Stowe</surname><given-names>R</given-names></string-name>, <string-name><surname>Patel</surname><given-names>S</given-names></string-name>, <string-name><surname>Rick</surname><given-names>C</given-names></string-name>, <string-name><surname>Gray</surname><given-names>R</given-names></string-name>, <string-name><surname>Clarke</surname><given-names>CE</given-names></string-name>. <article-title>Systematic review of levodopa dose equivalency reporting in Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>2010</year>;<volume>25</volume>:<fpage>2649</fpage>–<lpage>2685</lpage>.<pub-id pub-id-type="pmid">21069833</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0137">
                <label>137</label>
                <mixed-citation publication-type="book" id="mds27460-cit-0137"><person-group person-group-type="editor"><name><surname>Moore</surname><given-names>BCJ</given-names></name></person-group>, ed. <source xml:lang="en">An Introduction to the Psychology of Hearing</source>. <publisher-loc>San Diego, CA</publisher-loc>: <publisher-name>Academic</publisher-name>; <year>1997</year>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0138">
                <label>138</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0138"><string-name><surname>Smith</surname><given-names>ME</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Dromey</surname><given-names>C</given-names></string-name>, <string-name><surname>Perez</surname><given-names>KS</given-names></string-name>, <string-name><surname>Samandari</surname><given-names>R</given-names></string-name>. <article-title>Intensive voice treatment in Parkinson disease: laryngostroboscopic findings</article-title>. <source xml:lang="en">J Voice</source><year>1995</year>;<volume>9</volume>:<fpage>453</fpage>–<lpage>459</lpage>.<pub-id pub-id-type="pmid">8574314</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0139">
                <label>139</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0139"><string-name><surname>Liotti</surname><given-names>M</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Vogel</surname><given-names>D</given-names></string-name>, et al. <article-title>Hypophonia in Parkinson's disease: neural correlates of voice treatment revealed by PET</article-title>. <source xml:lang="en">Neurology</source><year>2003</year>;<volume>60</volume>:<fpage>432</fpage>–<lpage>440</lpage>.<pub-id pub-id-type="pmid">12578924</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0140">
                <label>140</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0140"><string-name><surname>Narayana</surname><given-names>S</given-names></string-name>, <string-name><surname>Fox</surname><given-names>PT</given-names></string-name>, <string-name><surname>Zhang</surname><given-names>W</given-names></string-name>, et al. <article-title>Neural correlates of efficacy of voice therapy in Parkinson's disease identified by performance—correlation analysis</article-title>. <source xml:lang="en">Hum Brain Mapp</source><year>2010</year>;<volume>31</volume>:<fpage>222</fpage>–<lpage>236</lpage>.<pub-id pub-id-type="pmid">19639554</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0141">
                <label>141</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0141"><string-name><surname>Narayana</surname><given-names>S</given-names></string-name>, <string-name><surname>Franklin</surname><given-names>C</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>E</given-names></string-name>, <string-name><surname>Robin</surname><given-names>D</given-names></string-name>, <string-name><surname>Fox</surname><given-names>PT</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <article-title>Voice therapy normalizes feedforward and feedback networks of the speech motor system</article-title>. <source xml:lang="en">Mov Disord</source><year>2017</year>;<volume>32</volume>(<issue>Suppl 2</issue>):<fpage>A1365</fpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0142">
                <label>142</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0142"><string-name><surname>Narayana</surname><given-names>S</given-names></string-name>, <string-name><surname>Franklin</surname><given-names>C</given-names></string-name>, <string-name><surname>Peterson</surname><given-names>E</given-names></string-name>, <string-name><surname>Robin</surname><given-names>D</given-names></string-name>, <string-name><surname>Fox</surname><given-names>PT</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO.</given-names></string-name> Voice therapy normalizes feedforward and feedback networks of the speech motor system. Poster presented at: The International Conference on Functional Mapping of the Human Brain; <year>2017b</year> June 25–29; Vancouver, British Columbia, Canada.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0143">
                <label>143</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0143"><string-name><surname>Huang</surname><given-names>JH</given-names></string-name>, <string-name><surname>Su</surname><given-names>QM</given-names></string-name>, <string-name><surname>Yang</surname><given-names>J</given-names></string-name>, et al. <article-title>Sample sizes in dosage investigational clinical trials: a systematic evaluation</article-title>. <source xml:lang="en">Drug Des Dev Ther</source><year>2015</year>;<volume>9</volume>:<fpage>305</fpage>–<lpage>312</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0144">
                <label>144</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0144"><string-name><surname>Schenkman</surname><given-names>M</given-names></string-name>, <string-name><surname>Hall</surname><given-names>DA</given-names></string-name>, <string-name><surname>Barón</surname><given-names>AE</given-names></string-name>, <string-name><surname>Schwartz</surname><given-names>RS</given-names></string-name>, <string-name><surname>Mettler</surname><given-names>P</given-names></string-name>, <string-name><surname>Kohrt</surname><given-names>WM</given-names></string-name>. <article-title>Exercise for people in early‐ or mid‐stage Parkinson disease: a 16‐month randomized controlled trial</article-title>. <source xml:lang="en">Phys Ther</source><year>2012</year>;<volume>92</volume>:<fpage>1395</fpage>–<lpage>1410</lpage>.<pub-id pub-id-type="pmid">22822237</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0145">
                <label>145</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0145"><string-name><surname>Countryman</surname><given-names>S</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Pawlas</surname><given-names>A</given-names></string-name>. <article-title>Speech and voice deficits in Parkinsonian plus syndromes: can they be treated?</article-title><source xml:lang="en">J Med Speech Lang Pathol</source><year>1994</year>;<volume>2</volume>:<fpage>211</fpage>–<lpage>225</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0146">
                <label>146</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0146"><string-name><surname>Spielman</surname><given-names>JL</given-names></string-name>, <string-name><surname>Mahler</surname><given-names>L</given-names></string-name>, <string-name><surname>Halpern</surname><given-names>A</given-names></string-name>, <string-name><surname>Gilley</surname><given-names>P</given-names></string-name>, <string-name><surname>Klepitskaya</surname><given-names>O</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <article-title>Intensive voice treatment (LSVT®LOUD) for Parkinson's disease following deep brain stimulation of the subthalamic nucleus</article-title>. <source xml:lang="en">J Commun Disord</source><year>2011</year>;<volume>44</volume>:<fpage>688</fpage>–<lpage>700</lpage>.<pub-id pub-id-type="pmid">21724193</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0147">
                <label>147</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0147"><string-name><surname>Sale</surname><given-names>P</given-names></string-name>, <string-name><surname>Castiglioni</surname><given-names>D</given-names></string-name>, <string-name><surname>De Pandis</surname><given-names>MF</given-names></string-name>, et al. <article-title>The Lee Silverman Voice Treatment (LSVT®) speech therapy in progressive supranuclear palsy</article-title>. <source xml:lang="en">Eur J Phys Rehabil Med</source><year>2015</year>;<volume>51</volume>:<fpage>569</fpage>–<lpage>574</lpage>.<pub-id pub-id-type="pmid">26138088</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0148">
                <label>148</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0148"><string-name><surname>Countryman</surname><given-names>S</given-names></string-name>, <string-name><surname>Hicks</surname><given-names>J</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Smith</surname><given-names>ME</given-names></string-name>. <article-title>Supraglottal hyperadduction in an individual with Parkinson disease: a clinical treatment note</article-title>. <source xml:lang="en">Am J Speech Lang Pathol</source><year>1997</year>;<volume>6</volume>:<fpage>74</fpage>–<lpage>84</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0149">
                <label>149</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0149"><string-name><surname>Theodoros</surname><given-names>DG</given-names></string-name>, <string-name><surname>Thompson‐Ward</surname><given-names>EC</given-names></string-name>, <string-name><surname>Murdoch</surname><given-names>BE</given-names></string-name>, <string-name><surname>Lethlean</surname><given-names>J</given-names></string-name>, <string-name><surname>Silburn</surname><given-names>P</given-names></string-name>. <article-title>The effects of the Lee Silverman Voice Treatment program on motor speech function in Parkinson disease following thalamotomy and pallidotomy surgery: a case study</article-title>. <source xml:lang="en">J Med Speech Lang Pathol</source><year>1999</year>;<volume>7</volume>:<fpage>157</fpage>–<lpage>160</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0150">
                <label>150</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0150"><string-name><surname>Constantinescu</surname><given-names>G</given-names></string-name>, <string-name><surname>Theodoros</surname><given-names>D</given-names></string-name>, <string-name><surname>Russell</surname><given-names>T</given-names></string-name>, <string-name><surname>Ward</surname><given-names>E</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>S</given-names></string-name>, <string-name><surname>Wootton</surname><given-names>R</given-names></string-name>. <article-title>Treating disordered speech and voice in Parkinson's disease online: a randomized controlled non‐inferiority trial</article-title>. <source xml:lang="en">Int J Lang Commun Disord</source><year>2011</year>;<volume>46</volume>:<fpage>1</fpage>–<lpage>16</lpage>.<pub-id pub-id-type="pmid">21281410</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0151">
                <label>151</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0151"><string-name><surname>Howell</surname><given-names>S</given-names></string-name>, <string-name><surname>Tripoliti</surname><given-names>E</given-names></string-name>, <string-name><surname>Pring</surname><given-names>T</given-names></string-name>. <article-title>Delivering the Lee Silverman Voice Treatment (LSVT) by web camera: a feasibility study</article-title>. <source xml:lang="en">Int J Lang Commun Disord</source><year>2009</year>;<volume>44</volume>:<fpage>287</fpage>–<lpage>300</lpage>.<pub-id pub-id-type="pmid">18821113</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0152">
                <label>152</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0152"><string-name><surname>Theodoros</surname><given-names>DG</given-names></string-name>, <string-name><surname>Constantinescu</surname><given-names>G</given-names></string-name>, <string-name><surname>Russell</surname><given-names>TG</given-names></string-name>, <string-name><surname>Ward</surname><given-names>EC</given-names></string-name>, <string-name><surname>Wilson</surname><given-names>SJ</given-names></string-name>, <string-name><surname>Wootton</surname><given-names>R</given-names></string-name>. <article-title>Treating the speech disorder in Parkinson's disease online</article-title>. <source xml:lang="en">J Telemed Telecare</source><year>2006</year>;<volume>12</volume>:<fpage>88</fpage>–<lpage>91</lpage>.<pub-id pub-id-type="pmid">16539756</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0153">
                <label>153</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0153"><string-name><surname>Theodoros</surname><given-names>DG</given-names></string-name>, <string-name><surname>Hill</surname><given-names>AJ</given-names></string-name>, <string-name><surname>Russell</surname><given-names>TG</given-names></string-name>. <article-title>Clinical and quality of life outcomes of speech treatment for Parkinson's disease delivered to the home via telerehabilitation: a noninferiority randomized controlled trial</article-title>. <source xml:lang="en">Am J Speech Lang Pathol</source><year>2016</year>;<volume>25</volume>:<fpage>214</fpage>–<lpage>232</lpage>.<pub-id pub-id-type="pmid">27145396</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0154">
                <label>154</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0154"><string-name><surname>Ward</surname><given-names>EC</given-names></string-name>, <string-name><surname>Theodoros</surname><given-names>DG</given-names></string-name>, <string-name><surname>Murdoch</surname><given-names>BE</given-names></string-name>, <string-name><surname>Silburn</surname><given-names>P</given-names></string-name>. <article-title>Changes in maximum capacity tongue function following the Lee Silverman Voice Treatment program</article-title>. <source xml:lang="en">J Med Speech Lang Pathol</source><year>2000</year>;<volume>8</volume>:<fpage>331</fpage>–<lpage>335</lpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0155">
                <label>155</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0155"><string-name><surname>Sauvageau</surname><given-names>VM</given-names></string-name>, <string-name><surname>Roy</surname><given-names>JP</given-names></string-name>, <string-name><surname>Langlois</surname><given-names>M</given-names></string-name>, <string-name><surname>Macoir</surname><given-names>J</given-names></string-name>. <article-title>Impact of the LSVT on vowel articulation and coarticulation in Parkinson's disease</article-title>. <source xml:lang="en">Clin Linguist Phon</source><year>2015</year>;<volume>29</volume>:<fpage>424</fpage>–<lpage>440</lpage>.<pub-id pub-id-type="pmid">25688915</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0156">
                <label>156</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0156"><string-name><surname>Cannito</surname><given-names>MP</given-names></string-name>, <string-name><surname>Suiter</surname><given-names>DM</given-names></string-name>, <string-name><surname>Beverly</surname><given-names>D</given-names></string-name>, <string-name><surname>Chorna</surname><given-names>L</given-names></string-name>, <string-name><surname>Wolf</surname><given-names>T</given-names></string-name>, <string-name><surname>Pfeiffer</surname><given-names>RM</given-names></string-name>. <article-title>Sentence intelligibility before and after voice treatment in speakers with idiopathic Parkinson's disease</article-title>. <source xml:lang="en">J Voice</source><year>2012</year>;<volume>26</volume>:<fpage>214</fpage>–<lpage>219</lpage>.<pub-id pub-id-type="pmid">22209057</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0157">
                <label>157</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0157"><string-name><surname>Whitehill</surname><given-names>TL</given-names></string-name>, <string-name><surname>Wong</surname><given-names>LL</given-names></string-name>. <article-title>Effect of intensive voice treatment on tone‐language speakers with Parkinson's disease</article-title>. <source xml:lang="en">Clin Linguist Phon</source><year>2007</year>;<volume>21</volume>:<fpage>919</fpage>–<lpage>925</lpage>.<pub-id pub-id-type="pmid">17972188</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0158">
                <label>158</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0158"><collab collab-type="authors">LSVT</collab>
Global [Internet]. LSVT LOUD‐Clinicians. Available at: <ext-link ext-link-type="uri" xlink:href="http://www.lsvtglobal.com/">http://www.lsvtglobal.com/</ext-link>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0159">
                <label>159</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0159"><string-name><surname>Brauer</surname><given-names>T</given-names></string-name>, <string-name><surname>Penner</surname><given-names>H</given-names></string-name>, <string-name><surname>Benecke</surname><given-names>P</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>. <article-title>Global implementation of efficacious voice treatment for Parkinson disease: LSVT LOUD: Germany</article-title>. <source xml:lang="en">Mov Disord</source><year>2015</year>;<volume>31</volume>:<fpage>S691</fpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0160">
                <label>160</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0160"><string-name><surname>Holroyd</surname><given-names>KA</given-names></string-name>, <string-name><surname>Penzien</surname><given-names>DB</given-names></string-name>, <string-name><surname>Hursey</surname><given-names>KG</given-names></string-name>, et al. <article-title>Change mechanisms in EMG biofeedback training: cognitive changes underlying improvements in tension headache</article-title>. <source xml:lang="en">J Consult Clin Psychol</source><year>1984</year>;<volume>52</volume>:<fpage>1039</fpage>–<lpage>1053</lpage>.<pub-id pub-id-type="pmid">6520274</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0161">
                <label>161</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0161"><string-name><surname>Lam</surname><given-names>J</given-names></string-name>, <string-name><surname>Tjaden</surname><given-names>K</given-names></string-name>. <article-title>Clear speech variants: an acoustic study in Parkinson's disease</article-title>. <source xml:lang="en">J Speech Lang Hear Res</source><year>2016</year>;<volume>59</volume>:<fpage>631</fpage>–<lpage>646</lpage>.<pub-id pub-id-type="pmid">27355431</pub-id></mixed-citation>
              </ref>
              <ref id="mds27460-bib-0162">
                <label>162</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0162"><string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, <string-name><surname>Levy</surname><given-names>ES</given-names></string-name>, <string-name><surname>Fox</surname><given-names>CM</given-names></string-name>, et al. <article-title>Impact of LSVT LOUD and LSVT ARTIC on speech intelligibility in Parkinson's disease</article-title>. <source xml:lang="en">Mov Disord</source><year>2015</year>;<volume>30</volume>:<fpage>S112</fpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0163">
                <label>163</label>
                <mixed-citation publication-type="miscellaneous" id="mds27460-cit-0163"><string-name><surname>Spielman</surname><given-names>J</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>L</given-names></string-name>, <string-name><surname>Freeman</surname><given-names>K</given-names></string-name>, <string-name><surname>Halpern</surname><given-names>A</given-names></string-name>, Maryn Y. Effects of Intensive Voice (LSVT LOUD) and Articulation (LSVT ARTIC) Treatments on Voice Quality in People with Parkinson Disease. Poster session presented at: The Annual Conference of the American Speech‐Language Hearing Association; <year>2017</year> November 9–11; Los Angeles, CA.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0164">
                <label>164</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0164"><string-name><surname>McFarland</surname><given-names>D</given-names></string-name>, <string-name><surname>Martin‐Harris</surname><given-names>B</given-names></string-name>, <string-name><surname>Ramig</surname><given-names>LO</given-names></string-name>, et al. <article-title>The impact of intensive voice treatment on swallowing in Parkinson disease [abstract]</article-title>. <source xml:lang="en">Mov Disord</source><year>2017</year>;<volume>32</volume>(<issue>Suppl 2</issue>) :<fpage>A130</fpage>.</mixed-citation>
              </ref>
              <ref id="mds27460-bib-0165">
                <label>165</label>
                <mixed-citation publication-type="journal" id="mds27460-cit-0165"><string-name><surname>Dumer</surname><given-names>AI</given-names></string-name>, <string-name><surname>Oster</surname><given-names>H</given-names></string-name>, <string-name><surname>McCabe</surname><given-names>D</given-names></string-name>, et al. <article-title>Effects of the Lee Silverman Voice Treatment (LSVT® LOUD) on hypomimia in Parkinson's disease</article-title>. <source xml:lang="en">J Int Neuropsychologic Soc</source><year>2014</year>;<volume>20</volume>:<fpage>302</fpage>–<lpage>312</lpage>.</mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
